var title_f18_0_18432="Type III supracondylar fracture";
var content_f18_0_18432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Type III supracondylar fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 191px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) This 5-year-old girl fell on her fully extended left hand. Her elbow is displaced in the posterior direction similar to an older patient with a dislocated elbow. B) The radiograph shows a displaced supracondylar fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baskin M. Trauma: Extremeties. In: Atlas of pediatric emergency medicine, Fleisher GR, Ludwig S, Baskin M (Eds), Lippincott Williams &amp; Wilkins 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18432=[""].join("\n");
var outline_f18_0_18432=null;
var title_f18_0_18433="Sinus node pacemaker sites";
var content_f18_0_18433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Location of pacemaker sites in the human sinus node",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 402px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Filled circles represent the location of sites under autonomic control, while the open circles are \"escape\" sites that are not under the control of the autonomic nervous system and are capable of generating ectopic impulses. There is a predominant clustering of all sites along the sulcus terminalis and superior vena caval (SVC)-right atrial (RA) junction in the upper posterior right atrium; a few escape sites are also located in the left atrium, below the pulmonary vein (PV). Stimulation of the parasympathetic nervous system shifts the dominant pacemaker site to a more caudal region of the sinus complex, while sympathetic stimulation shifts the site to a more cranial location.",
"    <div class=\"footnotes\">",
"     LAA: left atrial appendage; RAA: right atrial appendage.",
"    </div>",
"    <div class=\"reference\">",
"     From Boineau, JP, Canavan, TE, Schuessler, RB, et al Circulation 1988; 77:1221.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18433=[""].join("\n");
var outline_f18_0_18433=null;
var title_f18_0_18434="Patient information: EEG (The Basics)";
var content_f18_0_18434=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16567\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/57/39824\">",
"         EEG (electroencephalogram)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?30/5/30802\">",
"         Patient information: Epilepsy and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/40/43650\">",
"         Patient information: Epilepsy in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/54/38754\">",
"         Patient information: Epilepsy in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/56/28546\">",
"         Patient information: Seizures (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?33/27/34229\">",
"         Patient information: Seizures in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/26/419\">",
"         Patient information: Seizures in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: EEG (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/eeg-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H22391230\">",
"      <span class=\"h1\">",
"       What is an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An EEG is a test that measures electrical activity in the brain and records brain wave patterns. EEG is short for &ldquo;electroencephalogram.&rdquo;",
"     </p>",
"     <p>",
"      Normally, people have certain brain wave patterns when they are awake, asleep, and doing different activities. Some brain conditions can cause a person&rsquo;s brain wave patterns to be abnormal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391245\">",
"      <span class=\"h1\">",
"       Why might my doctor order an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor might order an EEG to diagnose a brain condition or get more information about a known brain condition. You might have an EEG if you:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Have seizures &ndash; Seizures are waves of abnormal electrical activity in the brain. Seizures can make you pass out, or move or behave strangely. An EEG can give your doctor information about your seizures.",
"       </li>",
"       <li>",
"        Have a brain tumor, brain injury, sleep problems, or memory problems",
"       </li>",
"       <li>",
"        Are going to have brain surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      A doctor might also order an EEG to check the brain activity of a person in a coma.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391259\">",
"      <span class=\"h1\">",
"       How do I prepare for an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To prepare for an EEG, you should:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wash your hair the night before your EEG with shampoo only. Don&rsquo;t put any conditioner, cream, or gel in your hair.",
"       </li>",
"       <li>",
"        Not eat or drink anything with caffeine in it for 8 hours beforehand.",
"       </li>",
"       <li>",
"        Follow your doctor&rsquo;s instructions about taking your medicines. You might need to take your usual medicines and doses. Or you might need to change your medicines.",
"       </li>",
"       <li>",
"        Follow your doctor&rsquo;s instructions about sleep. You might need to stay awake the night before your EEG. If you do, you will need to stay awake without drinking coffee or energy drinks.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391274\">",
"      <span class=\"h1\">",
"       What happens during an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An EEG can take place in a lab, office, or hospital.",
"     </p>",
"     <p>",
"      At the start of the EEG, a technician will stick electrodes onto your scalp using paste (",
"      <a class=\"graphic graphic_figure graphicRef55691 \" href=\"UTD.htm?38/57/39824\">",
"       figure 1",
"      </a>",
"      ). Some people wear a special cap with electrodes on it instead of having electrodes put on their scalp. Wires run from the electrodes to a computer that will record your brain activity.",
"     </p>",
"     <p>",
"      After the electrodes are in place, you will lie on a bed or lean back in a chair. Your doctor might give you medicine to make you sleepy. You will need to stay still and close your eyes. The technician will ask you to do different things at different times during the EEG. He or she might have you look at a flashing light, or breathe in and out deeply and quickly.",
"     </p>",
"     <p>",
"      An EEG usually takes about 20 minutes. But some EEGs last longer. People can have an EEG for a few hours or overnight. In those cases, a video camera will record them during their EEG. Some people have an &ldquo;ambulatory EEG.&rdquo; After the electrodes are in place, they go home. The EEG records their brain waves for a few days while they do their usual activities.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391289\">",
"      <span class=\"h1\">",
"       What happens after an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After an EEG, the technician will remove the electrodes or the cap. Most people can go about their usual activities. But if your doctor gave you medicine to make you sleepy, you will feel sleepy for a while. In that case, you should have another person drive you home.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391304\">",
"      <span class=\"h1\">",
"       What are the downsides of an EEG?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There aren&rsquo;t usually any downsides to having an EEG. The procedure is painless. An EEG only gets information from your brain. It does not do anything to your brain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391319\">",
"      <span class=\"h1\">",
"       What should I know about the results?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should know that an EEG doesn&rsquo;t always give a doctor helpful information. That&rsquo;s because an EEG records brain activity only for a short time.",
"     </p>",
"     <p>",
"      People can have a normal EEG even if they have seizures or another brain condition. Your doctor will use your EEG results along with your exam and other results to diagnose or manage your condition. If your doctor thinks that another EEG would be helpful, he or she might have you do an EEG that lasts longer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22391334\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=see_link\">",
"       Patient information: Seizures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/40/43650?source=see_link\">",
"       Patient information: Epilepsy in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/54/38754?source=see_link\">",
"       Patient information: Epilepsy in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=see_link\">",
"       Patient information: Epilepsy and pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/27/34229?source=see_link\">",
"       Patient information: Seizures in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=see_link\">",
"       Patient information: Seizures in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?18/0/18434?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16567 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-B60670ABF6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18434=[""].join("\n");
var outline_f18_0_18434=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391230\">",
"      What is an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391245\">",
"      Why might my doctor order an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391259\">",
"      How do I prepare for an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391274\">",
"      What happens during an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391289\">",
"      What happens after an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391304\">",
"      What are the downsides of an EEG?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391319\">",
"      What should I know about the results?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22391334\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16567\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/57/39824\">",
"      EEG (electroencephalogram)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=related_link\">",
"      Patient information: Epilepsy and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/40/43650?source=related_link\">",
"      Patient information: Epilepsy in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/54/38754?source=related_link\">",
"      Patient information: Epilepsy in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=related_link\">",
"      Patient information: Seizures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/27/34229?source=related_link\">",
"      Patient information: Seizures in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=related_link\">",
"      Patient information: Seizures in children (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18435="Perineal anatomy";
var content_f18_0_18435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Anatomy of the female perineum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18435=[""].join("\n");
var outline_f18_0_18435=null;
var title_f18_0_18436="Lidocaine and hydrocortisone: Patient drug information";
var content_f18_0_18436=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lidocaine and hydrocortisone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/14/34020?source=see_link\">",
"     see \"Lidocaine and hydrocortisone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F188703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AnaMantle HC&reg; Cream;",
"     </li>",
"     <li>",
"      AnaMantle HC&reg; Forte;",
"     </li>",
"     <li>",
"      AnaMantle HC&reg; Gel;",
"     </li>",
"     <li>",
"      LidaMantle HC&reg;;",
"     </li>",
"     <li>",
"      LidaMantle HC&reg; Relief Pad&trade;;",
"     </li>",
"     <li>",
"      LidoCort&trade;;",
"     </li>",
"     <li>",
"      Peranex&trade; HC;",
"     </li>",
"     <li>",
"      Peranex&trade; HC Medi-Pad;",
"     </li>",
"     <li>",
"      RectaGel&trade; HC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin rashes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat signs of hemorrhoids or rectal irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lidocaine, hydrocortisone, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705519",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Rectal:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699010",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bleeding from rectum or rectal pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705519",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Rectal:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696190",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use rectal cream rectally.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11196 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-99A7E1262A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18436=[""].join("\n");
var outline_f18_0_18436=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188703\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015098\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015097\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015102\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015103\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015105\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015100\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015101\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015106\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015107\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/14/34020?source=related_link\">",
"      Lidocaine and hydrocortisone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18437="Piroxicam: Patient drug information";
var content_f18_0_18437=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Piroxicam: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=see_link\">",
"     see \"Piroxicam: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/33/37399?source=see_link\">",
"     see \"Piroxicam: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F210653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Feldene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F210654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Piroxicam&reg;;",
"     </li>",
"     <li>",
"      Dom-Piroxicam;",
"     </li>",
"     <li>",
"      Novo-Pirocam;",
"     </li>",
"     <li>",
"      Nu-Pirox;",
"     </li>",
"     <li>",
"      PMS-Piroxicam",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691600",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain and swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702749",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to piroxicam or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231864",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have GI (gastrointestinal) bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis. Do not take more often than every 24 hours unless told to do so by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10980 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-481C146FAB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18437=[""].join("\n");
var outline_f18_0_18437=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210653\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210654\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030075\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030077\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030076\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030081\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030082\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030084\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030079\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030080\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030085\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030086\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=related_link\">",
"      Piroxicam: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/33/37399?source=related_link\">",
"      Piroxicam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18438="Congenital TEF fluoro";
var content_f18_0_18438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50963%7EPULM%2F56998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50963%7EPULM%2F56998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital tracheoesophageal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Congenital fistula visualized after aspiration of barium. A distal tracheoesophageal fistula connects the esophagus with the airway at the level of the carina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant tracheoesophageal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scan shows a tracheoesophageal fistula due to advanced esophageal carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18438=[""].join("\n");
var outline_f18_0_18438=null;
var title_f18_0_18439="Alopecia areata 1";
var content_f18_0_18439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Alopecia areata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This discrete area of hair loss is characteristic of alopecia areata.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18439=[""].join("\n");
var outline_f18_0_18439=null;
var title_f18_0_18440="Perioperative heart failure in noncardiac surgery";
var content_f18_0_18440=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Perioperative heart failure in noncardiac surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Peter F Weissmann, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Steven D Hillson, MD, MSc, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Stephen S Gottlieb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18440/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/0/18440/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure (HF) is one of the most common conditions requiring evaluation and treatment in the perioperative period. Preoperative HF has been identified as a risk factor for other cardiac complications after surgery and often requires postponing surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. It is also the most frequently encountered postoperative cardiac complication of noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The clinical implications of HF around the time of major noncardiac surgery are reviewed here and recommendations are made for evaluation and treatment.",
"   </p>",
"   <p>",
"    General treatment of heart failure due to systolic or diastolic dysfunction and perioperative management of hypertrophic cardiomyopathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=see_link\">",
"     \"Treatment and prognosis of diastolic heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22696?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of hypertrophic cardiomyopathy management including treatment of special problems\", section on 'Perioperative management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE AND ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HF occurs in 1 to 6 percent of patients after major surgery. The risk is higher, between 6 and 25 percent, in patients with existing cardiac conditions such as coronary artery disease, prior HF, or valvular heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ]. Risk may also be increased for patients with diabetes mellitus or renal insufficiency, in cases of high risk surgery such as vascular surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/7\">",
"     7",
"    </a>",
"    ], or when an excessive volume of fluid is administered intraoperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postoperative pulmonary edema can have etiologies other than HF. Pulmonary edema resulting from post-anesthesia laryngospasm has been described, often in young adults who are otherwise healthy and undergoing only minor operative procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. This syndrome, sometimes called \"negative pressure pulmonary edema,\" is poorly understood and often not recognized. It may occur in as many as 0.1 percent of all anesthesia cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/14\">",
"     14",
"    </a>",
"    ]. The prognosis for complete recovery in these patients is excellent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Other causes of postoperative pulmonary edema include lateral decubitus positioning during surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/16\">",
"     16",
"    </a>",
"    ], pneumonectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/17-19\">",
"     17-19",
"    </a>",
"    ], lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/20\">",
"     20",
"    </a>",
"    ], cocaine use [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/21,22\">",
"     21,22",
"    </a>",
"    ], or rarely pheochromocytoma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11434?source=see_link\">",
"     \"Overview of the management of postoperative pulmonary complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HF AS A RISK FACTOR FOR POSTOPERATIVE CARDIAC COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative HF is an important risk factor for postoperative cardiac complications [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/1-4,24\">",
"     1-4,24",
"    </a>",
"    ]. Several well designed studies support this conclusion, but the precise definition of HF has varied among studies. Whether clinical signs and symptoms of HF at the time of a preoperative examination confer greater risk than a distant history of HF has been studied, but findings have been inconsistent.",
"   </p>",
"   <p>",
"    Although HF is a risk factor for adverse outcomes in patients undergoing noncardiac surgery, the magnitude of risk in such patients is influenced by the presence or absence of other risk factors (",
"    <a class=\"graphic graphic_table graphicRef57075 \" href=\"UTD.htm?42/4/43083\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef80422 \" href=\"UTD.htm?39/24/40332\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The literature on perioperative HF does not distinguish between various etiologies of HF. As an example, no study has been published that answers whether the risk for a patient with HF from ischemic cardiomyopathy is the same as the risk for a patient with HF from diastolic dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREOPERATIVE SCREENING FOR HEART FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on perioperative care for noncardiac surgery recommend that decompensated (NYHA class IV, worsening, or new-onset) HF should be evaluated and treated before noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Preoperative management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The question has been raised whether to screen for mild HF",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    asymptomatic left ventricular dysfunction in patients scheduled for major surgery since HF is an important risk factor for adverse perioperative cardiac outcomes. Screening methods include history and physical examination, assessment of exercise tolerance or direct assessment of cardiac function under rest or stress conditions. There is limited evidence to support such screening.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    perioperative guidelines recommend that every effort be made to detect unsuspected HF by careful history and physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. The guidelines noted the importance of identifying the cause of HF, if possible, since the cause (eg, coronary heart disease) may have implications for perioperative risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Assessment of left ventricular function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiographic determination of left ventricular function may help predict adverse cardiac outcomes perioperatively, but does not appear to add important information to the clinical evaluation. This was illustrated in a study that evaluated 339 men with known or suspected coronary disease who were undergoing noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/26\">",
"     26",
"    </a>",
"    ]. A left ventricular ejection fraction less than 40 percent was a significant predictor of the combined cardiac outcome of postoperative cardiac ischemia, HF, and ventricular tachycardia. However, adding that echocardiographic information to predictive models that contained known clinical risk factors did not alter sensitivity, specificity, or predictive values in clinically important ways. Similarly, a second study in 85 patients undergoing vascular surgery found no relationship between preoperative ejection fraction and postoperative myocardial infarction or death, regardless of clinical history [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these largely negative findings there are suggestions that noninvasive testing may be a useful stratification method in some patients. A study of 53 high-risk patients with known or suspected coronary disease undergoing a variety of major nonvascular procedures found that LV systolic dysfunction was the only independent predictor of postoperative pulmonary edema in a multivariate model [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/28\">",
"     28",
"    </a>",
"    ]. However, it is difficult to predict which patients may benefit from echocardiography, and the bulk of the data suggest that it should not be considered a routine part of the preoperative evaluation. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Recommendations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Dobutamine echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography (DSE) may add predictive value above that of using only clinical variables, but its greatest value appears to be in the detection of inducible ischemia rather than LV dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link&amp;anchor=H37#H37\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\", section on 'Dobutamine echocardiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Exercise tolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poor exercise tolerance, as measured by patient self report, predicts serious postoperative events including cardiac events. One study showed that an inability to walk four blocks and climb two flights of stairs was 71 percent sensitive and 47 percent specific for serious postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/29\">",
"     29",
"    </a>",
"    ]. However, it is not clear that such limits on exercise tolerance represented LV dysfunction, and known HF was a stronger predictor than poor exercise tolerance in both univariate and multivariate models.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interpretation of the role of noninvasive testing for HF is complicated by the overlap between HF and coronary disease. Several studies have indicated the value of stress testing to detect major coronary disease in certain high-risk patients and guidelines have addressed this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25,30\">",
"     25,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the value of detecting LV dysfunction preoperatively is less clear. Given the costs of testing, the limited evidence of demonstrable benefit, and the lack of data on how the results of testing should affect management, we do not recommend routine preoperative echocardiography or other left ventricular functional testing either to detect previously unidentified HF or to evaluate known HF that appears clinically compensated.",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    preoperative guidelines for noncardiac surgery concluded that routine perioperative evaluation of LV function is not indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. Such testing was considered reasonable for patients with dyspnea of unknown origin, and for patients with current or prior HF with worsening dyspnea or other change in clinical status.",
"   </p>",
"   <p>",
"    On the other hand, assessing exercise capacity by asking patients the number of blocks they can walk and the number of stairs they can climb appears to be an inexpensive way to stratify risk [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25,29\">",
"     25,29",
"    </a>",
"    ]. Further testing may be useful in selected patients who are unable either to exercise or to provide an assessment of exertional capacity, and who are otherwise at high cardiac risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PREOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little evidence from well performed studies on how to manage HF in the preoperative period. In general, patients with a history of HF who are asymptomatic at the time of surgery should continue their current medical regimen; recommendations regarding the perioperative management of specific cardiovascular medications are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H3#H3\">",
"     \"Perioperative medication management\", section on 'Cardiovascular medications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of perioperative cardiac complications is roughly doubled when clinical signs of HF are present preoperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/3\">",
"     3",
"    </a>",
"    ]. Although there is limited evidence that treatment of HF reduces this risk, decompensated HF should be treated and stabilized to the extent possible before surgery. The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    perioperative guidelines for noncardiac surgery recommended that decompensated (NYHA class IV, worsening, or new-onset) HF should be evaluated and treated before noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. Postponement of surgery is often appropriate while this is accomplished [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25,31\">",
"     25,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    How best to optimize clinical status has not been established. Given the paucity of evidence, we recommend a similar approach to that used for the general management of HF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: General considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     ACE inhibitors and diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin converting enzyme (ACE) inhibitors and diuretics are important components of HF management and are generally recommended as first-line therapy for patients with newly diagnosed HF preoperatively. However, delayed initiation of ACE inhibitor therapy (or reduction or discontinuation of ongoing ACE inhibitor therapy) is appropriate in patients with acute decompensated heart failure when acute hypotension is a concern. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=see_link\">",
"     \"ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: General considerations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=see_link\">",
"     \"Use of diuretics in patients with heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ACE inhibitors can generally be safely administered in the perioperative period. Although their use may be associated with perioperative hypotension, the benefits generally outweigh the risks in patients with HF. Diuretics are also typically safe perioperatively as long as close attention is paid to volume and electrolyte (potassium) status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H7#H7\">",
"     \"Perioperative medication management\", section on 'ACE inhibitors and angiotensin II receptor blockers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H8#H8\">",
"     \"Perioperative medication management\", section on 'Diuretics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term HF outcomes are improved with beta blocker therapy. Patients who are already receiving and tolerating beta blockers should generally continue such therapy perioperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initiation of beta blockade perioperatively is controversial. There is no convincing evidence of benefit from routine initiation of beta blocker therapy in patients undergoing noncardiac surgery and, in a large randomized trial, potential harm was noted [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/32\">",
"     32",
"    </a>",
"    ]. There is some evidence supporting benefit in patients at particularly high risk (eg, revised Goldman cardiac risk index &ge;3) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/33\">",
"     33",
"    </a>",
"    ]; HF is one risk factor in this model (",
"    <a class=\"graphic graphic_table graphicRef57075 \" href=\"UTD.htm?42/4/43083\">",
"     table 1",
"    </a>",
"    ). These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=see_link&amp;anchor=H17#H17\">",
"     \"Management of cardiac risk for noncardiac surgery\", section on 'Role of beta blockers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal approach to initiation of beta blocker therapy in patients with HF undergoing noncardiac surgery is not well-defined. Since adequate beta blockade can take weeks or months to achieve safely in such patients, we prefer initiation of beta blockade in the preoperative period only if surgery can be substantially delayed. If surgery is urgent, we prefer postponing beta blockade until a later date.",
"   </p>",
"   <p>",
"    Initiation of beta blocker therapy is generally deferred in patients with acute decompensated HF [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: General considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Aldosterone antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aldosterone antagonists (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    ) are beneficial is selected patients with HF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link\">",
"     \"Use of aldosterone antagonists in heart failure\"",
"    </a>",
"    .) However, there is no evidence that aldosterone antagonist is useful in the perioperative period, and we regard its use as optional preoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Digoxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    is not well-defined in the perioperative period, but it is reasonable to consider as an adjunct to other therapies in patients with systolic dysfunction with persistent HF symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18504?source=see_link\">",
"     \"Use of digoxin in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of postoperative atrial fibrillation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=see_link\">",
"     \"Atrial fibrillation and flutter after cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Optimization of HF control",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear when to conclude that preoperative HF control has been optimized. One study found that in a univariate analysis patients with HF symptoms within the past week had a notably higher risk than patients with HF but not within the past week [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/34\">",
"     34",
"    </a>",
"    ]. However, this risk was not seen on multivariate analysis.",
"   </p>",
"   <p>",
"    We favor achieving control of clinical signs of HF for one week or longer if time permits. Although its utility and safety are in question, patients who clearly require urgent surgery and whose HF cannot be controlled quickly might be reasonable candidates for preoperative invasive monitoring with therapy directed by detailed hemodynamic assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INVASIVE PERIOPERATIVE MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians often recommend perioperative invasive cardiac monitoring with a pulmonary artery catheter (PAC) for patients with significantly diminished left ventricular systolic function, significant valvular disease, recent myocardial infarction, unstable angina, or other conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/35\">",
"     35",
"    </a>",
"    ]. Some authors advocate a preoperative \"tune-up,\" in which patients undergo PA catheterization in order to optimize hemodynamic parameters using volume infusion and vasopressors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, this approach is probably not beneficial in most patients. While a number of small randomized and non-randomized studies of variable quality have reached different conclusions ranging from benefits of PAC use to actual harm, the best performed study to date found no benefit with use of the PAC perioperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/38\">",
"     38",
"    </a>",
"    ]. In this report, 1994 high risk patients ages 60 years or older who were undergoing urgent or elective major surgery were randomly assigned to perioperative management with or without a PAC. There was no significant difference in in-hospital mortality between the two groups (7.8 versus 7.7 percent, respectively), in six month mortality (12.6 versus 11.9 percent), or in the rate of postoperative HF (12.9 versus 11.2 percent). The only significant difference was a higher rate of pulmonary embolism in the PAC group (0.9 versus 0 percent). These results are supported by a prospective cohort study of 4059 patients undergoing major noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vascular surgery carries a higher risk of cardiac complications than other forms of noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/5,24\">",
"     5,24",
"    </a>",
"    ]. Nevertheless, routine use of a PAC in patients undergoing vascular surgery is also probably not warranted. Although, one small, prospective randomized study of 89 patients undergoing limb-salvage arterial surgery found improved clinical outcomes among patients who received PAC monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/40\">",
"     40",
"    </a>",
"    ], a meta-analysis of randomized studies in patients undergoing vascular surgery did not find improved outcomes with PAC use [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/41\">",
"     41",
"    </a>",
"    ]. In addition, in the randomized study cited above, invasive monitoring with a PAC was not beneficial in the 1065 patients who were undergoing major vascular surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings suggest that invasive monitoring with a PAC should not be part of routine perioperative management. Nevertheless, despite a lack of evidence, one group who might benefit from invasive monitoring are patients with symptomatic HF who need to undergo emergency surgery before their HF can be stabilized.",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines concluded that routine perioperative PAC use is not recommended, especially in patients at low risk of developing hemodynamic instability [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"     25",
"    </a>",
"    ]. Consideration of preoperative intensive PAC monitoring for optimization of hemodynamic status should be restricted to selected patients with an unstable and complex presentation and multiple comorbid conditions. The guidelines also noted that perioperative use of a PAC may be reasonable in patients at risk for major hemodynamic disturbances that are easily detected by a PAC. However, the decision must be based on patient disease, surgical procedure (expectation of associated fluid shifts), and practice setting (PAC experience to reduce the risk of potentially harmful incorrect interpretation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other monitoring methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternatives to PA catheterization have been proposed, including esophageal Doppler monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/42\">",
"     42",
"    </a>",
"    ]. Whether such alternatives lead to improved clinical outcomes or other measurable benefits is currently unproven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE FLUID MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fluid management of patients with HF can be especially challenging. Preoperative consultations that recommend \"avoid volume overload\" are not particularly helpful, since neither the anesthesia team nor surgical service intends to precipitate heart failure or a volume overload state. Intraoperative fluid administration is required to maintain insensible losses at a rate of 2 mL per kilogram per hour and 3 mL of crystalloid for each mL of blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IV fluid restriction may not prevent the development of HF. Adequate preload is necessary for myocardial contractility, and reducing the effective circulating volume may have a negative effect upon cardiac function. In a retrospective study of surgical patients that examined the risks for developing postoperative HF, patients who had net gains (input and output) of less than 500 mL per hour appeared to be at greater risk for postoperative HF than those receiving more than 500 mL per hour net [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/7\">",
"     7",
"    </a>",
"    ]. The rate of HF was also higher in patients who had a greater than 40 mmHg increase or decrease in mean arterial pressure during surgery compared to baseline, and in those with prior cardiac disease or diabetes mellitus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE ASSESSMENT AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative shortness of breath can have many etiologies other than pulmonary edema (",
"    <a class=\"graphic graphic_table graphicRef55082 \" href=\"UTD.htm?25/5/25691\">",
"     table 3",
"    </a>",
"    ). The general assessment of postoperative patients who are short of breath is complex and beyond the scope of this review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11434?source=see_link\">",
"     \"Overview of the management of postoperative pulmonary complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     General assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;All postoperative patients found to be in pulmonary edema should be evaluated for new or unstable myocardial ischemia. This assessment can be challenging since postoperative myocardial infarctions often present atypically and may have different etiologies than myocardial infarctions that occur outside of the perioperative setting. As with patients in other settings, when new myocardial ischemia is suspected, the evaluation should include cardiac monitoring, electrocardiography, and serial cardiac enzyme measurements.",
"   </p>",
"   <p>",
"    Physicians should also pay close attention to volume infusion perioperatively, examining records from both the operating room and the immediate postoperative period. Excessive fluid administration is a common cause of postoperative pulmonary edema. One series of thirteen fatal cases of postoperative pulmonary edema found fluid administration of at least 67",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    (approximately 5 liters for a 70 kg individual) in the initial 24 postoperative hours [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/9\">",
"     9",
"    </a>",
"    ]. Twelve of the 13 patients had no known prior cardiac disease, and in eight of the patients, cardiopulmonary arrest was the first sign of pulmonary edema. The authors did not examine the amount of fluid administration in a control group of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;We treat postoperative pulmonary edema, once its cause has been diagnosed, no differently in the postoperative period than the way it would be managed during a general medical service admission for HF. Diuretics are usually given acutely. Angiotensin converting enzyme inhibition and beta blockade are added for patients with decreased left ventricular systolic function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Nonischemic pulmonary edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who experience pulmonary edema postoperatively, but who have not had a myocardial infarction, can be successfully treated on a surgical service with appropriate medical consultation. These patients have no worse prognosis long term than patients without acute pulmonary edema. A study that followed 444 patients with coronary disease or significant coronary risk factors for two years after major noncardiac surgery found that 76 patients (17 percent) suffered cardiac complications in the immediate postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18440/abstract/6\">",
"     6",
"    </a>",
"    ]. Of these, eight had active myocardial ischemia (six with nonfatal infarctions and two with unstable angina) and 30 had HF without active ischemia. Only those patients with active postoperative ischemia had a worse prognosis over the two year follow-up period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Ischemic pulmonary edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative ischemia is a common etiology of HF and presents some management difficulties in the postoperative period; these patients are ideally managed by physicians experienced in perioperative cardiac care. Ischemia cannot be managed with anticoagulant medications until hemostasis is achieved at the operative site. Thrombolytic therapy is rarely an option because of potential bleeding in the postoperative period and because postoperative myocardial infarctions usually do not present with a clearly defined onset of chest pain or with typical ECG changes, making it difficult to know the length of time that has elapsed since the infarction began.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Evaluation and prognosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Echocardiography is not routinely indicated for assessing left ventricular systolic function in clinically stable patients. Echocardiography is reasonable in patients with symptoms or signs of new or worsening HF. Asking patients about the distance they can walk and number of stairs they can climb can help stratify risk.",
"     </li>",
"     <li>",
"      The cause of new or newly decompensated heart failure HF identified by preoperative history and physical examination should be evaluated before major elective surgery.",
"     </li>",
"     <li>",
"      Signs of HF at the time of surgery probably confer greater risk than a history of prior HF that is compensated at the time of the preoperative examination.",
"     </li>",
"     <li>",
"      It is unclear whether some causes of HF confer greater risk than others.",
"     </li>",
"     <li>",
"      In the absence of new or active myocardial ischemia, postoperative pulmonary edema does not affect long-term prognosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decompensated HF should be optimally treated before major elective surgery. Postponement of surgery may be appropriate until this is accomplished.",
"     </li>",
"     <li>",
"      Routine initiation of perioperative beta blocker therapy is of unproven benefit and associated with potential harm. There is some evidence supporting benefit in patients at particularly high risk (eg, revised Goldman cardiac risk index &ge;3); HF is one risk factor in this model (",
"      <a class=\"graphic graphic_table graphicRef57075 \" href=\"UTD.htm?42/4/43083\">",
"       table 1",
"      </a>",
"      ). In such patients, beta blocker therapy should optimally be initiated weeks or more before surgery. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Beta blockers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The routine use of perioperative invasive monitoring is not recommended. Such monitoring may be considered in unstable patients with HF requiring immediate surgery. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Invasive perioperative monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients found to have postoperative HF should be evaluated for new or unstable myocardial ischemia. If there is no evidence for new or active ischemia, pulmonary edema should be initially managed with diuretics.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/1\">",
"      Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/2\">",
"      Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001; 345:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/3\">",
"      Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986; 146:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/4\">",
"      Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/5\">",
"      Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/6\">",
"      Mangano DT, Browner WS, Hollenberg M, et al. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/7\">",
"      Charlson ME, MacKenzie CR, Gold JP, et al. Risk for postoperative congestive heart failure. Surg Gynecol Obstet 1991; 172:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/8\">",
"      Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/9\">",
"      Arieff AI. Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest 1999; 115:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/10\">",
"      Herrick IA, Mahendran B, Penny FJ. Postobstructive pulmonary edema following anesthesia. J Clin Anesth 1990; 2:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/11\">",
"      Holmes JR, Hensinger RN, Wojtys EW. Postoperative pulmonary edema in young, athletic adults. Am J Sports Med 1991; 19:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/12\">",
"      Scarbrough FE, Wittenberg JM, Smith BR, Adcock DK. Pulmonary edema following postoperative laryngospasm: case reports and review of the literature. Anesth Prog 1997; 44:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/13\">",
"      Lavertu P, Gervais AJ. Recurrent noncardiogenic pulmonary edema secondary to obstruction by hemiepiglottic remnant. J Otolaryngol 1988; 17:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/14\">",
"      McConkey PP. Postobstructive pulmonary oedema--a case series and review. Anaesth Intensive Care 2000; 28:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/15\">",
"      Lathan SR, Silverman ME, Thomas BL, Waters WC 4th. Postoperative pulmonary edema. South Med J 1999; 92:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/16\">",
"      Snoy FJ, Woodside JR. Unilateral pulmonary edema (down lung syndrome) following urological operation. J Urol 1984; 132:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/17\">",
"      Wittnich C, Trudel J, Zidulka A, Chiu RC. Misleading \"pulmonary wedge pressure\" after pneumonectomy: its importance in postoperative fluid therapy. Ann Thorac Surg 1986; 42:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/18\">",
"      Waller DA, Gebitekin C, Saunders NR, Walker DR. Noncardiogenic pulmonary edema complicating lung resection. Ann Thorac Surg 1993; 55:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/19\">",
"      Deslauriers J, Aucoin A, Gr&eacute;goire J. Postpneumonectomy pulmonary edema. Chest Surg Clin N Am 1998; 8:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/20\">",
"      Ablett MJ, Grainger AJ, Keir MJ, Mitchell L. The correlation of the radiologic extent of lung transplantation edema with pulmonary oxygenation. AJR Am J Roentgenol 1998; 171:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/21\">",
"      Singh PP, Dimich I, Shamsi A. Intraoperative pulmonary oedema in a young cocaine smoker. Can J Anaesth 1994; 41:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/22\">",
"      Bloomfield EL. Post-operative pulmonary edema in a former cocaine addict. Mil Med 1992; 157:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/23\">",
"      Fahmy N, Assaad M, Bathija P, Whittier FC. Postoperative acute pulmonary edema: a rare presentation of pheochromocytoma. Clin Nephrol 1997; 48:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/24\">",
"      Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/25\">",
"      Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120:e169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/26\">",
"      Halm EA, Browner WS, Tubau JF, et al. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 1996; 125:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/27\">",
"      Franco CD, Goldsmith J, Veith FJ, et al. Resting gated pool ejection fraction: a poor predictor of perioperative myocardial infarction in patients undergoing vascular surgery for infrainguinal bypass grafting. J Vasc Surg 1989; 10:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/28\">",
"      Takase B, Younis LT, Byers SL, et al. Comparative prognostic value of clinical risk indexes, resting two-dimensional echocardiography, and dipyridamole stress thallium-201 myocardial imaging for perioperative cardiac events in major nonvascular surgery patients. Am Heart J 1993; 126:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/29\">",
"      Reilly DF, McNeely MJ, Doerner D, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/30\">",
"      Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257.",
"     </a>",
"    </li>",
"    <li>",
"     Gross, RJ, Caputo, GM and Kammerer, WS. Kammerer and Gross' Medical Consultation: The Internist on Surgical, Obstetric, and Psychiatric Services. Lippincott, Williams &amp; Wilkins, Baltimore 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/32\">",
"      POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/33\">",
"      Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/34\">",
"      Kumar R, McKinney WP, Raj G, et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001; 16:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/35\">",
"      Sola JE, Bender JS. Use of the pulmonary artery catheter to reduce operative complications. Surg Clin North Am 1993; 73:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/36\">",
"      Shoemaker WC, Kram HB, Appel PL, Fleming AW. The efficacy of central venous and pulmonary artery catheters and therapy based upon them in reducing mortality and morbidity. Arch Surg 1990; 125:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/37\">",
"      Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/38\">",
"      Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/39\">",
"      Polanczyk CA, Rohde LE, Goldman L, et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA 2001; 286:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/40\">",
"      Berlauk JF, Abrams JH, Gilmour IJ, et al. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg 1991; 214:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/41\">",
"      Barone JE, Tucker JB, Rassias D, Corvo PR. Routine perioperative pulmonary artery catheterization has no effect on rate of complications in vascular surgery: a meta-analysis. Am Surg 2001; 67:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18440/abstract/42\">",
"      Madan AK, UyBarreta VV, Aliabadi-Wahle S, et al. Esophageal Doppler ultrasound monitor versus pulmonary artery catheter in the hemodynamic management of critically ill surgical patients. J Trauma 1999; 46:607.",
"     </a>",
"    </li>",
"    <li>",
"     Stoelting RK, Miller RD. Fluid and blood therapy. In: Basics of Anesthesia, 2nd ed, Churchill Livingston, New York 1989. p.245.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3489 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-91.202.164.29-FFA7B79098-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18440=[""].join("\n");
var outline_f18_0_18440=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE AND ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HF AS A RISK FACTOR FOR POSTOPERATIVE CARDIAC COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREOPERATIVE SCREENING FOR HEART FAILURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Assessment of left ventricular function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Dobutamine echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Exercise tolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PREOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ACE inhibitors and diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Aldosterone antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Digoxin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Optimization of HF control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INVASIVE PERIOPERATIVE MONITORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other monitoring methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      INTRAOPERATIVE FLUID MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      POSTOPERATIVE ASSESSMENT AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      General assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Nonischemic pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Ischemic pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Evaluation and prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3489\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3489|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/4/43083\" title=\"table 1\">",
"      Revised cardiac risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/24/40332\" title=\"table 2\">",
"      Detsky cardiac risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/5/25691\" title=\"table 3\">",
"      Causes of postop dyspnea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=related_link\">",
"      ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=related_link\">",
"      Atrial fibrillation and flutter after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=related_link\">",
"      Management of cardiac risk for noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22696?source=related_link\">",
"      Overview of hypertrophic cardiomyopathy management including treatment of special problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11434?source=related_link\">",
"      Overview of the management of postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=related_link\">",
"      Treatment and prognosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=related_link\">",
"      Treatment of acute decompensated heart failure: General considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=related_link\">",
"      Use of aldosterone antagonists in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18504?source=related_link\">",
"      Use of digoxin in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=related_link\">",
"      Use of diuretics in patients with heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18441="Dietary recommendations for toddlers, preschool, and school-age children";
var content_f18_0_18441=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dietary recommendations for toddlers, preschool, and school-age children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18441/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/0/18441/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nutritional requirements, feeding development, and dietary guidelines for toddlers (12 to 24 months), preschool, and school-age children will be discussed here. Nutritional needs of infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=see_link\">",
"     \"Introducing solid foods and vitamin and mineral supplementation during infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NUTRITIONAL REQUIREMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Energy and nutrient requirements for children vary depending upon age, sex, and activity level (",
"    <a class=\"graphic graphic_table graphicRef78274 \" href=\"UTD.htm?4/46/4845\">",
"     table 1",
"    </a>",
"    ).",
"    <a class=\"external\" href=\"file://www.choosemyplate.gov/\">",
"     ChooseMyPlate",
"    </a>",
"    is an interactive Web site that provides individual dietary guidance according to these parameters. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Energy intake is influenced by the number of meals and snacks that are eaten during the day, the energy density of foods consumed, and portion size. Children generally can self-regulate energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, self-regulation may be overridden if eating behaviors are driven by factors other than hunger and fullness (eg, coercive feeding, restriction of intake, environmental cues to eat) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Parents should provide a range of nutritious foods for meals and snacks, but children should be allowed to decide how much, if any, they eat [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/5\">",
"     5",
"    </a>",
"    ]. Parents must be cognizant that peers and others outside the family greatly influence food choices of school-age children and adolescents. Body image concerns and societal attitudes may affect the energy intake and nutritional status of older children. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Eating environment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Energy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Energy is provided through three primary macronutrients: protein, fat, and carbohydrates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Protein should comprise 6 to 20 percent of total energy intake for children one to three years of age, and 10 to 30 percent of total energy intake for children 4 to 18 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Fat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary fat is an important source of energy, supports the transport of fat-soluble vitamins, and provides the two essential fatty acids, alpha-linolenic acid (omega-3 group) (ALA) and linoleic acid (omega-6 group) (LA). Total fat intake should be between 30 and 35 percent of energy intake for children two to three years of age; total fat intake should be between 25 and 35 percent of energy intake for children 4 to 18 years of age. Essential fatty acid intake, primarily as linoleic acid, should be 3 percent of total daily energy intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Carbohydrate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbohydrates are an important source of energy and support the transport of vitamins, minerals, and trace elements. Adequate carbohydrate intake contributes to sufficient intake of dietary fiber, iron, thiamine, niacin, riboflavin, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    . Carbohydrates should comprise 45 to 65 percent of total energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Micronutrients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micronutrients include vitamins, minerals, and trace elements. Dietary Reference Intakes (DRI) for micronutrients are available through the",
"    <a class=\"external\" href=\"file://fnic.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=1\">",
"     United States Department of Agriculture Food and Nutrition Information Center",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link&amp;anchor=H11#H11\">",
"     \"Dietary history and recommended dietary intake in children\", section on 'Dietary Reference Intakes (DRIs)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FEEDING DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Achieving independence and mastery of feeding skills is an important developmental task of early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Allowing the child to feed him or herself promotes and reinforces self-regulation of intake.",
"   </p>",
"   <p>",
"    Key issues for toddlers and preschool children include making the transition to cup and utensil feeding, fluctuations in appetite, achieving adequate iron and zinc intake, avoiding overconsumption of juice and sweetened beverages, and developing routines for healthy eating and activity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. Key issues for school-age children include adequate intake of fruits, vegetables, calcium, vitamin D, and fiber; avoidance of",
"    <span class=\"nowrap\">",
"     energy-rich/nutrient-poor",
"    </span>",
"    snacks (eg, salty snacks, cookies, sweetened beverages) and overconsumption of sugar-sweetened foods and beverages; and development of a healthy body image [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,11\">",
"     8,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children who have developmental delays may not master feeding skills in a timely fashion. Parents should understand that the prolonged use of a bottle or the persistence of finger feeding may be necessary to insure adequate dietary energy and nutrient intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Toddlers",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the second year of life, through the progressive acquisition of motor skills and eruption of the full complement of deciduous teeth, children learn to feed themselves independently and make the transition to a modified adult diet [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Dietary preferences and patterns continue to be established [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The growth rate and appetite decrease after the first birthday. Toddlers may eat variable quantities at any given meal. They also may choose from a small variety of foods [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. These behaviors are to be expected [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/2,8\">",
"     2,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H179339885\">",
"    <span class=\"h3\">",
"     Feeding development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feeding development during the second year includes acquisition of the following skills [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drinking from a cup. Weaning from the bottle should begin at 12 to 15 months of age. By 15 months of age, children can manage a cup by themselves but will continue to spill; by 18 to 24 months of age, cup manipulation is improved, and spills occur less frequently.",
"      <br/>",
"      <br/>",
"      Toddlers should be completely transitioned from the bottle to the cup by two years of age (ideally by 15 to 18 months), and they should not sleep with a bottle. Drinking from a bottle predisposes to dental caries, particularly if the bottle is taken to bed or sipped throughout the day. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=see_link&amp;anchor=H12#H12\">",
"       \"Preventive dental care and counseling for infants and young children\", section on 'Dietary habits'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In addition, supplying large volumes of caloric beverages in a bottle may lead either to overfeeding or to decreased solid food intake and undernutrition. Continuing to use a bottle at two years was associated with obesity at 5.5 years in a longitudinal cohort study [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Self-feeding. During the second one-half of the first year, infants learn to grasp food with their hands and then between the thumb and first finger; they can use their lips to remove food from a spoon. By 16 to 17 months of age, improved wrist rotation permits the transfer of food from a bowl to the mouth.",
"     </li>",
"     <li>",
"      By 24 months of age, most children are ready to consume an adult diet (with modifications to prevent choking). (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Choking'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H179339902\">",
"    <span class=\"h3\">",
"     Feeding behaviors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal toddler feeding behaviors include [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Playing with food. Exploratory behaviors (touching, smelling, putting the food in the mouth and spitting it out) may precede acceptance or willingness to taste or swallow new foods [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decrease in dietary variety (feeding \"jags\"). Beginning at about two years of age, toddlers may become resistant to trying new foods; they may choose to eat only a small number of well-accepted favorites [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/2,12\">",
"       2,12",
"      </a>",
"      ]. It may be necessary to offer new foods several times (as many as 8 to 10) before concluding that the child will not accept them [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,15-17\">",
"       8,15-17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Preschool children",
"    </span>",
"    &nbsp;&mdash;&nbsp;By three to four years of age, children are better able to protect their airways and can safely consume the small, round, hard foods that previously posed a choking hazard. They can handle utensils and cups efficiently and can sit at the table for meals [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preschool children are more aware of the feeding environment than younger children, and environmental cues affect their food selection and intake patterns [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Environmental cues include time of day, portion size, restriction of food or pressure to eat, the preferences and eating behaviors of others, and packaging (eg, the presence of licensed characters on the package) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preschool children may have unpredictable interest in eating [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Their ability to sit at the table may be limited by their attention span. However, they should be encouraged to sit with the family for a reasonable period of time (eg, 15 to 20 minutes) during meals, even if they choose not to eat. Sitting with the family during meals provides an opportunity for caregivers to model healthy eating behaviors and choices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     School-age children",
"    </span>",
"    &nbsp;&mdash;&nbsp;School-age children can understand basic nutrition concepts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. They can help with meal planning, food preparation, and mealtime chores (eg, setting the table) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    School-age children have more freedom over their food choices; many eat at least one meal per day away from home. Allowing them to participate in food choices at home and providing positive reinforcement when they make healthy choices may help them to make healthy choices away from home.",
"   </p>",
"   <p>",
"    School-age children also are more aware of their body weight and shape than when they were younger. The food attitudes and choices of school-age children may be influenced (positively or negatively) by friends, nonfamily members,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the media [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Parents may need to balance these potentially negative influences by increasing positive influences in the home (eg, by making healthy choices themselves during family meals, increasing reinforcement when the child makes healthy choices, and setting an example).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIETARY GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fostering the development of healthy eating behaviors is an important goal of early childhood nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Several national health organizations have issued dietary guidelines for children and adolescents. These groups include the American Academy of Pediatrics (AAP), the American Heart Association (AHA), the American Dietetic Association, and the United States Departments of Agriculture and Health and Human Services",
"    <span class=\"nowrap\">",
"     (USDA/HHS)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,11,23,24\">",
"     8,11,23,24",
"    </a>",
"    ]. The recommendations from the various organizations are relatively consistent and are summarized below (",
"    <a class=\"graphic graphic_table graphicRef79084 \" href=\"UTD.htm?5/60/6093\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     USDA/HHS",
"    </span>",
"    devised ChooseMyPlate, an interactive Web site, to facilitate implementation of the",
"    <span class=\"nowrap\">",
"     USDA/HHS",
"    </span>",
"    dietary guidelines for individuals older than two years.",
"    <a class=\"external\" href=\"file://www.choosemyplate.gov/\">",
"     ChooseMyPlate",
"    </a>",
"    provides individual dietary guidance based upon age, sex, and physical activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dietary composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young children have the innate ability to adjust their energy intake to the energy density of their diet, but not to choose a well-balanced diet [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/2,12,25,26\">",
"     2,12,25,26",
"    </a>",
"    ]. They depend upon adults to offer them a variety of nutritious, developmentally appropriate foods to meet the recommended number of servings per day (",
"    <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"     table 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of nutrient-dense foods from the basic food groups should be offered each day (",
"    <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"     table 4",
"    </a>",
"    ). Foods and beverages should contain or be prepared with little added salt, sugar, or caloric sweeteners [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,11,24\">",
"     8,11,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Fat and cholesterol",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended intake of fat and cholesterol varies depending on age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,24\">",
"     8,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fat and cholesterol intake are not restricted for children younger than two years.",
"     </li>",
"     <li>",
"      Total fat intake should be between 30 and 35 percent of energy intake for children two to three years of age; total fat intake should be between 25 and 35 percent of energy intake for children 4 to 18 years of age. Fat intake should not be restricted below 20 percent of total energy intake.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most fats should come from polyunsaturated and monounsaturated fatty acids (",
"    <a class=\"graphic graphic_table graphicRef80214 \" href=\"UTD.htm?17/42/18091\">",
"     table 5",
"    </a>",
"    ). For children older than two years, saturated fats should make up less than 10 percent of total energy intake, cholesterol intake should be less than 300 mg per day, and the intake of trans fats should be as low as possible.",
"   </p>",
"   <p>",
"    The types of dietary fat are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=see_link\">",
"     \"Dietary fat\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Meat and protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;When choosing and preparing meat, poultry, and other high-protein foods, make choices that are lean, low fat, or fat free.",
"   </p>",
"   <p>",
"    An estimated 65 to 70 percent of protein intake should come from sources of high biologic value, typically animal products, which contain a full complement of essential amino acids. Animal products are not necessary to provide optimal protein, but most alternative sources from plants (eg, legumes, grains, nuts, seeds, and vegetables) do not contain a full complement of essential amino acids, and therefore greater dietary planning is required for diets without meat. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link&amp;anchor=H10#H10\">",
"     \"Vegetarian diets for children\", section on 'Protein'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Heart Association (AHA) recommends two servings of fish per week, not including commercially prepared fried fish, since these products may be high in trans fats and relatively low in omega-3 fatty acids [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/11,27\">",
"     11,27",
"    </a>",
"    ]. To balance the cardiovascular benefits of fish consumption with the possibility of mercury contamination, the United States Food and Drug Administration (FDA) recommends that children eat up to 12 ounces (two average meals) per week of fish with low levels of mercury (eg, shrimp, canned light tuna, salmon, pollack, and catfish), but that young children avoid consumption of shark, swordfish, king mackerel, and tile fish (sometimes called golden bass or golden snapper) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/11,28\">",
"     11,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=see_link\">",
"     \"Fish oil and marine omega-3 fatty acids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many sources of protein are also common allergens (eg, milk, eggs, soy, fish, shellfish, peanuts, and tree nuts). Insuring adequate protein intake in children with food allergies is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=see_link&amp;anchor=H4#H4\">",
"     \"Nutritional issues in food allergy\", section on 'Protein'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Fruits and vegetables",
"    </span>",
"    &nbsp;&mdash;&nbsp;A colorful variety of fruits and vegetables should be offered each day (",
"    <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"     table 4",
"    </a>",
"    ). Strategies that parents can use to increase fruit and vegetable consumption include [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Provide &ldquo;hands on&rdquo; experience with fruits and vegetables through gardening and cooking",
"     </li>",
"     <li>",
"      Involve children in the selection and preparation of fruits and vegetables",
"     </li>",
"     <li>",
"      Cut fruits and vegetables into shapes that the child can dip",
"     </li>",
"     <li>",
"      Expose children to a variety of fruits and vegetables",
"     </li>",
"     <li>",
"      Being a role model by eating fruits and vegetables for snacks and during meals",
"     </li>",
"     <li>",
"      Making fruits and vegetables more accessible",
"     </li>",
"     <li>",
"      Add vegetables to sandwiches, pasta, chili, soups, casseroles, and pizza",
"     </li>",
"     <li>",
"      Add fruit to cereal or pancakes",
"     </li>",
"     <li>",
"      Provide fruits and vegetables as snacks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No more than one-half of the recommended daily servings of fruit should be provided in the form of fruit juice [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/30\">",
"     30",
"    </a>",
"    ]. One 4-ounce glass of 100 percent fruit juice equals one fruit serving for children two to three years of age, and one 6-ounce glass of 100 percent fruit juice equals one fruit serving for children older than three years.",
"   </p>",
"   <p>",
"    Children between one and six years of age should limit fruit juice consumption to 4 to 6 ounces per day [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/30\">",
"     30",
"    </a>",
"    ]. Children older than seven years should limit fruit juice consumption to 8 to 12 ounces. Fruit juice generally lacks the fiber of whole fruit and provides no nutritional advantage. Reliance on fruit juice to provide the recommended daily intake of fruit does not promote eating behaviors associated with consumption of whole fruits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Grains",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least one-half of total grains consumed should be whole grains.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Fiber",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimum intake of dietary fiber for infants and children younger than two years of age is not known. Studies of weaning diets with the gradual introduction of solid foods, including increased fiber, suggest that an intake of 5 grams per day is beneficial provided the children ingest adequate calories, vitamins, and minerals [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For children older than two years, a safe range of fiber intake equals the age (in years) plus 5 to 10 g per day (maximum 30 g per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. This goal is best met by eating a variety of fiber-rich fruits, vegetables, cereals, and whole-grain products. One-half cup of vegetables or one piece of fruit provides approximately 3 g of fiber.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Cow's milk/calcium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children between 12 and 24 months of age generally should drink whole cow's milk (rather than skim milk, 1 percent milk, or 2 percent milk) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. However, the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents recommends that the decision to use whole or reduced-fat milk for children between 12 and 24 months of age be made on a case-by-case basis by the parents and pediatric health care provider [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/35\">",
"     35",
"    </a>",
"    ]. Factors to be considered in the decision include the child&rsquo;s growth, appetite, intake of other nutrient-dense foods, intake of other fat sources, and potential risk for obesity and cardiovascular disease. Consumption of skim or low-fat milk should only be undertaken if the child&rsquo;s overall diet supplies 30 percent of energy intake from fat. Children between 12 and 24 months of age should consume at least 2 cups (each cup equals 8 ounces and contains approximately 300 mg of calcium) per day and eat foods rich in calcium to meet their daily calcium requirement (700",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    Excessive milk intake can displace the desire for foods that fulfill nutritional requirements (eg, iron). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children older than two years should consume fat-free (skim) or low-fat milk (1 percent milk, 2 percent milk) or equivalent products. Children between two and eight years should consume at least 2 to 3 cups per day and eat foods rich in calcium to meet their daily calcium requirement (700",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for children 1 to 3 years, and 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for children 4 to 8 years), and children and adolescents 9 to 18 years should consume at least 3 cups per day and eat foods rich in calcium to meet their daily calcium requirement (1300",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vitamin D requirements and recommendations for meeting the recommended daily intake of vitamin D are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H23365817#H23365817\">",
"     \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Recommendations for vitamin D intake'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Snacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Snacks are an essential component of the young child's diet. Healthy snacks should be planned so they contribute to the day's total nutrient intake (",
"    <a class=\"graphic graphic_table graphicRef78274 \" href=\"UTD.htm?4/46/4845\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Healthy snacks include fresh fruit, cheese, whole-grain crackers, bread products, milk, raw vegetables, 100 percent fruit juices, sandwiches, peanut butter, and yogurt [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Sweetened beverages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The consumption of soft drinks and other sweetened beverages (eg, fruit drinks, flavored water) should be discouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9,37\">",
"     8,9,37",
"    </a>",
"    ]. These beverages are a major source of added sugar in the diet. Their consumption is associated with lower intake of key nutrients (particularly calcium) because they generally are consumed instead of milk. Plain, unflavored water is the preferred beverage for children, particularly when fluids are consumed outside of meals and snacks [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Frequency of feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most young children should be fed four to six times per day [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Snacks are an essential component of the young child's diet. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Snacks'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Toddlers eat an average of seven times per day, with snacks accounting for approximately one-fourth of daily energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/15\">",
"     15",
"    </a>",
"    ]. Preschool children generally eat three meals and several small snacks per day. School-age children typically eat fewer meals and snacks per day than younger children, although they may continue to have a snack after school [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Children who skip breakfast tend to consume less energy and fewer nutrients than those who eat breakfast [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Portion size",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate portion size varies depending upon the child's age and the particular food (",
"    <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"     table 4",
"    </a>",
"    ). Serving children portions that are larger than recommended for their age may contribute to overeating. In a crossover study, preschool children who were repeatedly exposed to large portions (two times the size of an age-appropriate portion) during a series of lunches increased their total energy intake at lunch by 15 percent and their entree intake by 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/40\">",
"     40",
"    </a>",
"    ]. When permitted to select their own portion size, they consumed 25 percent less of the entree than when served the large portion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Vitamin and mineral supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine supplementation of vitamins and minerals is not necessary for healthy children who are growing normally and consume a varied diet [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9,41,42\">",
"     8,9,41,42",
"    </a>",
"    ]. In a survey of the dietary habits of infants and toddlers in the United States, more toddlers who received supplements had excessive nutrient intakes of vitamin A and zinc than those who did not (97 versus 15 percent and 68 versus 38 percent for vitamin A and zinc, respectively); 18 percent of toddlers who received supplements had excessive intake of folate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/41\">",
"     41",
"    </a>",
"    ]. In another national survey, supplement use contributed to excessive intake of vitamin A, vitamin C, iron, zinc, copper,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    among children 2 through 18 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If parents wish to give their children supplements, a standard pediatric multivitamin generally poses no risk. However, interactions with medications may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/43\">",
"     43",
"    </a>",
"    ]. Megadose vitamins and doses of any nutrient in excess of the recommended daily allowance should be discouraged because of the potential toxic effects. Vitamin and mineral supplements, particularly those designed to appeal to children (eg, vitamin gum), should be kept out of reach of children.",
"   </p>",
"   <p>",
"    Vitamin and mineral supplements may be indicated for children at nutritional risk, including those [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      From neglected or deprived environments.",
"     </li>",
"     <li>",
"      With anorexia or inadequate appetite.",
"     </li>",
"     <li>",
"      With lead poisoning. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/5/21594?source=see_link&amp;anchor=H2#H2\">",
"       \"Childhood lead poisoning: Management\", section on 'Primary prevention'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With failure to thrive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=see_link&amp;anchor=H27#H27\">",
"       \"Poor weight gain in children older than two years of age\", section on 'Dietary intervention'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=see_link&amp;anchor=H15#H15\">",
"       \"Management of failure to thrive (undernutrition) in children younger than two years\", section on 'Vitamins and minerals'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Who do not get regular sunlight exposure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      do not have adequate vitamin D intake. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H722827#H722827\">",
"       \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Prevention'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      With chronic diseases that may affect absorption and utilization of nutrients. As examples, children with chronic liver disease or fat malabsorption (eg, cystic fibrosis) need supplementation of the fat-soluble vitamins A, D, E, and K, and children with hemolytic anemia (eg, sickle cell anemia) may need",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"       folic acid",
"      </a>",
"      supplementation.",
"     </li>",
"     <li>",
"      Who are trying to lose weight or are consuming fad or restrictive diets. As an example, children who consume strict vegan diets (avoidance of all animal products, including eggs, milk, and milk products) may need supplementation of vitamin B12, iron, or vitamin D. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link\">",
"       \"Vegetarian diets for children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link&amp;anchor=H6#H6\">",
"       \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Prevention of iron deficiency'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Food safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two major safety considerations when feeding children: choking and foodborne infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Choking",
"    </span>",
"    &nbsp;&mdash;&nbsp;To limit the risk of choking, children younger than three to four years of age should not be given small, round, hard foods (eg, hot dogs, nuts [particularly peanuts], grapes, raisins, raw carrots, popcorn, round candies). In addition [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Toddlers should always be supervised while eating",
"     </li>",
"     <li>",
"      Children should be seated upright during eating; they should not eat while reclining, walking, or running",
"     </li>",
"     <li>",
"      Children should not eat while riding in a car, because the parent may not be able to intervene if the child chokes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Foodborne infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;To minimize the risk of foodborne infection, children should not be fed [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,24\">",
"     8,24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Raw (unpasteurized) milk or juice",
"     </li>",
"     <li>",
"      Raw or partially cooked eggs or foods containing raw eggs",
"     </li>",
"     <li>",
"      Raw or undercooked meat, poultry, fish, or shellfish",
"     </li>",
"     <li>",
"      Raw sprouts",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ingestion of raw milk has been associated with various bacterial infections, including",
"    <em>",
"     Campylobacter",
"    </em>",
"    ,",
"    <em>",
"     Brucella",
"    </em>",
"    ,",
"    <em>",
"     Listeria monocytogenes",
"    </em>",
"    ,",
"    <em>",
"     Salmonella",
"    </em>",
"    , and",
"    <em>",
"     Escherichia coli",
"    </em>",
"    and associated hemolytic uremic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. The FDA mandates pasteurization in final package form for all milk and milk products for direct human consumption that are shipped for interstate sale [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/45,47\">",
"     45,47",
"    </a>",
"    ]. However, individual states regulate milk shipped within the state, and some states permit raw milk to be sold in some form to the public.",
"   </p>",
"   <p>",
"    Additional steps to prevent foodborne infection are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef73216 \" href=\"UTD.htm?4/17/4381\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16426?source=see_link&amp;anchor=H33#H33\">",
"     \"Food poisoning in children\", section on 'Prevention through safe food handling'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     EATING ENVIRONMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The eating environment is a critical factor in the development of healthy eating behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Structure and routine for all eating occasions are particularly important.",
"   </p>",
"   <p>",
"    The meal environment should be free from distractions. Eating should occur in a designated area, and the child should have a developmentally appropriate chair. Family meals provide an opportunity for children to learn healthy eating habits and begin to appreciate the social aspects of eating. In a meta-analysis of observational studies, children and adolescents who shared meals with their family &ge;3 times per week were more likely to be of normal weight and have healthy dietary and eating patterns, and less likely to engage in disordered eating than those who shared &lt;3 family meals per week [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The responsibility for establishing a healthy eating environment is divided between the child and the caregivers. The division of responsibility is based upon the child's ability to regulate intake and inability to choose a well-balanced diet [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/1,5,8\">",
"     1,5,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Caregiver responsibilities include [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Providing a variety of nutritious foods",
"     </li>",
"     <li>",
"      Defining the structure and timing of meals",
"     </li>",
"     <li>",
"      Creating a mealtime environment that facilitates eating and social exchange (eg, free of distractions)",
"     </li>",
"     <li>",
"      Recognizing and responding to the child's signals of hunger and fullness",
"     </li>",
"     <li>",
"      Modeling healthy eating behaviors (eg, consuming a varied diet)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The child's responsibilities include choosing what and how much of the foods offered by the caregiver to consume.",
"   </p>",
"   <p>",
"    Caregivers should understand that failure to accept new foods and \"eating jags\" are normal stages of child development [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8\">",
"     8",
"    </a>",
"    ]. Attempts to control the child's eating (eg, by pressuring them to eat specific foods or clean their plate, bribing, restricting foods) may make the child less sensitive to physiologic cues of satiety and hunger and contribute to overeating [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/8,25,49,50\">",
"     8,25,49,50",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Toddlers'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     DIETARY PATTERNS IN THE UNITED STATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2002 survey of the daily intakes of infants (4 to 11 months) and toddlers (12 to 24 months) in the United States indicates that most such children meet their nutritional needs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18441/abstract/15,51-53\">",
"     15,51-53",
"    </a>",
"    ]. However, recommendations regarding dietary composition and avoidance of trans fat, added sugar, and sweetened beverages are poorly followed, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      18 to 33 percent of infants and toddlers 7 to 24 months of age consumed no discrete servings of vegetables, and 23 to 33 percent consumed no fruits",
"     </li>",
"     <li>",
"      By 15 to 18 months of age, french fries were the most common vegetable consumed by toddlers",
"     </li>",
"     <li>",
"      By 19 to 24 months of age, 62 percent of toddlers consumed a baked dessert, 20 percent consumed candy, and 44 percent consumed a sweetened beverage on any given day",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.choosemyplate.gov/\">",
"       ChooseMyPlate",
"      </a>",
"      is an interactive Web site that provides individual dietary guidance according to age, sex, and activity level based upon the",
"      <span class=\"nowrap\">",
"       USDA/HHS",
"      </span>",
"      Dietary Guidelines for Americans (older than two years)",
"     </li>",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       USDA/HHS",
"      </span>",
"      <a class=\"external\" href=\"file://www.health.gov/DietaryGuidelines/\">",
"       Dietary Guidelines for Americans",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Energy and nutrient requirements for toddlers, preschool, and school-age children vary depending upon age, sex, and activity level (",
"      <a class=\"graphic graphic_table graphicRef78274 \" href=\"UTD.htm?4/46/4845\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Nutritional requirements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During the second year of life, children learn to feed themselves independently and make the transition to a modified adult diet. Achieving independence and mastery of feeding skills is an important developmental task of early childhood. It is normal for toddlers to eat variable quantities at any given meal, to become resistant to trying new foods, and to choose to eat a small number of favorite foods. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Toddlers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The feeding choices and behaviors of preschool children are largely influenced by environmental cues. It is important for preschool children to sit with the family during meal times (even if the child chooses not to eat) so that they can observe the eating behaviors and choices of family members. Children and adolescents who share meals with their family have better health outcomes. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Preschool children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The feeding choices and behaviors of school-age children may be influenced (positively or negatively) by friends, nonfamily members,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the media. Parents may need to balance these potentially negative influences by increasing positive influences in the home. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'School-age children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Young children can regulate their energy intake but rely on adults to offer them a variety of nutritious, developmentally appropriate foods for a well-balanced diet (",
"      <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Dietary guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary guidelines for children are summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef79084 \" href=\"UTD.htm?5/60/6093\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Dietary guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most young children should be fed four to six times per day. Snacks are an essential component of the young child's diet. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Frequency of feeding'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Snacks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate portion sizes vary depending upon the child's age and the particular food (",
"      <a class=\"graphic graphic_table graphicRef60734 \" href=\"UTD.htm?29/41/30365\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73489 \" href=\"UTD.htm?18/62/19437\">",
"       table 4",
"      </a>",
"      ). Serving children portions that are larger than recommended for their age may contribute to overeating. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Portion size'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine supplementation of vitamins and minerals is not necessary for healthy growing children who consume a varied diet. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Vitamin and mineral supplements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the establishment of a healthy eating environment, the caregiver is responsible for providing a variety of nutritious foods; defining the structure and timing of meals; creating a mealtime environment that facilitates eating and social exchange; and recognizing and responding to the child's signals of hunger and fullness. The child is responsible for participating in food selection and determining how much is consumed at each eating occasion. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Eating environment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/1\">",
"      Birch LL, Johnson SL, Andresen G, et al. The variability of young children's energy intake. N Engl J Med 1991; 324:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/2\">",
"      Nicklaus S, Chabanet C, Boggio V, Issanchou S. Food choices at lunch during the third year of life: increase in energy intake but decrease in variety. Acta Paediatr 2005; 94:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/3\">",
"      Fox MK, Devaney B, Reidy K, et al. Relationship between portion size and energy intake among infants and toddlers: evidence of self-regulation. J Am Diet Assoc 2006; 106:S77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/4\">",
"      Fomon SJ. Taste acquisition and appetite control. Pediatrics 2000; 106:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/5\">",
"      Satter EM. The feeding relationship. J Am Diet Assoc 1986; 86:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/6\">",
"      Trumbo P, Schlicker S, Yates AA, et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 2002; 102:1621.",
"     </a>",
"    </li>",
"    <li>",
"     USDA Dietary Reference Intakes (DRIs) file://fnic.nal.usda.gov/nal_display/index.php?tax_level=1&amp;info_center=4&amp;tax_subject=256html (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Feeding the Child. In: Pediatric Nutrition Handbook, 6th, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.145.",
"    </li>",
"    <li>",
"     Promoting healthy nutrition. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd, Hagan JF, Shaw JS, Duncan PM (Eds), American Acacemy of Pediatrics, Elk Grove Village, IL 2008. p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/10\">",
"      Picciano MF, Smiciklas-Wright H, Birch LL, et al. Nutritional guidance is needed during dietary transition in early childhood. Pediatrics 2000; 106:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/11\">",
"      Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 2005; 112:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/12\">",
"      Nicklaus S, Boggio V, Issanchou S. Food choices at lunch during the third year of life: high selection of animal and starchy foods but avoidance of vegetables. Acta Paediatr 2005; 94:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/13\">",
"      Gooze RA, Anderson SE, Whitaker RC. Prolonged bottle use and obesity at 5.5 years of age in US children. J Pediatr 2011; 159:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/14\">",
"      Johnson SL, Bellows L, Beckstrom L, Anderson J. Evaluation of a social marketing campaign targeting preschool children. Am J Health Behav 2007; 31:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/15\">",
"      Ziegler P, Hanson C, Ponza M, et al. Feeding Infants and Toddlers Study: meal and snack intakes of Hispanic and non-Hispanic infants and toddlers. J Am Diet Assoc 2006; 106:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/16\">",
"      Wardle J, Herrera ML, Cooke L, Gibson EL. Modifying children's food preferences: the effects of exposure and reward on acceptance of an unfamiliar vegetable. Eur J Clin Nutr 2003; 57:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/17\">",
"      Wardle J, Cooke LJ, Gibson EL, et al. Increasing children's acceptance of vegetables; a randomized trial of parent-led exposure. Appetite 2003; 40:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/18\">",
"      Roberto CA, Baik J, Harris JL, Brownell KD. Influence of licensed characters on children's taste and snack preferences. Pediatrics 2010; 126:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/19\">",
"      Lapierre MA, Vaala SE, Linebarger DL. Influence of licensed spokescharacters and health cues on children's ratings of cereal taste. Arch Pediatr Adolesc Med 2011; 165:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/20\">",
"      Mu&ntilde;oz KA, Krebs-Smith SM, Ballard-Barbash R, Cleveland LE. Food intakes of US children and adolescents compared with recommendations. Pediatrics 1997; 100:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/21\">",
"      Kant AK. Reported consumption of low-nutrient-density foods by American children and adolescents: nutritional and health correlates, NHANES III, 1988 to 1994. Arch Pediatr Adolesc Med 2003; 157:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/22\">",
"      Subar AF, Krebs-Smith SM, Cook A, Kahle LL. Dietary sources of nutrients among US children, 1989-1991. Pediatrics 1998; 102:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/23\">",
"      Hampl JS, Anderson JV, Mullis R, American Dietetic Association. Position of the American Dietetic Association: the role of dietetics professionals in health promotion and disease prevention. J Am Diet Assoc 2002; 102:1680.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. file://www.health.gov/dietaryguidelines/ (Accessed on June 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/25\">",
"      Johnson SL, Birch LL. Parents' and children's adiposity and eating style. Pediatrics 1994; 94:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/26\">",
"      Birch LL, Deysher M. Conditioned and unconditioned caloric compensation: evidence for self-regulation of food intake by young children. Learn Motiv 1985; 16:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/27\">",
"      Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747.",
"     </a>",
"    </li>",
"    <li>",
"     U.S Department of Health and Human Services and U.S. Environmental Progection Agency. What you need to know about mercury in fish and shellfish www.cfsan.fda.gov/~dms/admehg3.html (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/29\">",
"      Kim SA, Grimm KA, May AL, et al. Strategies for pediatric practitioners to increase fruit and vegetable consumption in children. Pediatr Clin North Am 2011; 58:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/30\">",
"      Committee on Nutrition. American Academy of Pediatrics: The use and misuse of fruit juice in pediatrics. Pediatrics 2001; 107:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/31\">",
"      Agostoni C, Riva E, Giovannini M. Dietary fiber in weaning foods of young children. Pediatrics 1995; 96:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/32\">",
"      Davidsson L, Mackenzie J, Kastenmayer P, et al. Dietary fiber in weaning cereals: a study of the effect on stool characteristics and absorption of energy, nitrogen, and minerals in healthy infants. J Pediatr Gastroenterol Nutr 1996; 22:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/33\">",
"      Williams CL, Bollella M, Wynder EL. A new recommendation for dietary fiber in childhood. Pediatrics 1995; 96:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/34\">",
"      Kranz S, Mitchell DC, Siega-Riz AM, Smiciklas-Wright H. Dietary fiber intake by American preschoolers is associated with more nutrient-dense diets. J Am Diet Assoc 2005; 105:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/35\">",
"      Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5:S213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/36\">",
"      Moore LL, Bradlee ML, Gao D, Singer MR. Effects of average childhood dairy intake on adolescent bone health. J Pediatr 2008; 153:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/37\">",
"      Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009; 120:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/38\">",
"      Morgan KJ, Zabik ME, Leveille GA. The role of breakfast in nutrient intake of 5- to 12-year-old children. Am J Clin Nutr 1981; 34:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/39\">",
"      Preziosi P, Galan P, Deheeger M, et al. Breakfast type, daily nutrient intakes and vitamin and mineral status of French children, adolescents, and adults. J Am Coll Nutr 1999; 18:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/40\">",
"      Orlet Fisher J, Rolls BJ, Birch LL. Children's bite size and intake of an entr&eacute;e are greater with large portions than with age-appropriate or self-selected portions. Am J Clin Nutr 2003; 77:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/41\">",
"      Briefel R, Hanson C, Fox MK, et al. Feeding Infants and Toddlers Study: do vitamin and mineral supplements contribute to nutrient adequacy or excess among US infants and toddlers? J Am Diet Assoc 2006; 106:S52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/42\">",
"      Bailey RL, Fulgoni VL 3rd, Keast DR, et al. Do dietary supplements improve micronutrient sufficiency in children and adolescents? J Pediatr 2012; 161:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/43\">",
"      Goldman RD, Vohra S, Rogovik AL. Potential vitamin-drug interactions in children: at a pediatric emergency department. Paediatr Drugs 2009; 11:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/44\">",
"      Rangel JM, Sparling PH, Crowe C, et al. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 2005; 11:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/45\">",
"      Centers for Disease Control and Prevention (CDC). Escherichia coli 0157:H7 infections in children associated with raw milk and raw colostrum from cows--California, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:625.",
"     </a>",
"    </li>",
"    <li>",
"     US Food and Drug Administration. Questions &amp;Answers: Raw Milk. file://www.fda.gov/food/foodsafety/product-specificinformation/milksafety/ucm122062.htm (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     Food and Drug Administration. Grade \"A\" pasteurized milk ordinance: 2003 revision. US Department of Health and Human Services Rockville, MD 2004. www.cfsan.fda.gov/~ear/pmo03toc.html (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/48\">",
"      Hammons AJ, Fiese BH. Is frequency of shared family meals related to the nutritional health of children and adolescents? Pediatrics 2011; 127:e1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/49\">",
"      Fisher JO, Birch LL. Restricting access to palatable foods affects children's behavioral response, food selection, and intake. Am J Clin Nutr 1999; 69:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/50\">",
"      Faith MS, Berkowitz RI, Stallings VA, et al. Parental feeding attitudes and styles and child body mass index: prospective analysis of a gene-environment interaction. Pediatrics 2004; 114:e429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/51\">",
"      Devaney B, Kalb L, Briefel R, et al. Feeding infants and toddlers study: overview of the study design. J Am Diet Assoc 2004; 104:s8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/52\">",
"      Fox MK, Pac S, Devaney B, Jankowski L. Feeding infants and toddlers study: What foods are infants and toddlers eating? J Am Diet Assoc 2004; 104:s22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18441/abstract/53\">",
"      Briefel R, Ziegler P, Novak T, Ponza M. Feeding Infants and Toddlers Study: characteristics and usual nutrient intake of Hispanic and non-Hispanic infants and toddlers. J Am Diet Assoc 2006; 106:S84.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2866 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-382E3F64B8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18441=[""].join("\n");
var outline_f18_0_18441=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NUTRITIONAL REQUIREMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Energy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Fat",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Carbohydrate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Micronutrients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FEEDING DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Toddlers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H179339885\">",
"      - Feeding development",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H179339902\">",
"      - Feeding behaviors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Preschool children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      School-age children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIETARY GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dietary composition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Fat and cholesterol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Meat and protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Fruits and vegetables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Grains",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Fiber",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Cow's milk/calcium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Snacks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Sweetened beverages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Frequency of feeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Portion size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Vitamin and mineral supplements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Food safety",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Choking",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Foodborne infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      EATING ENVIRONMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      DIETARY PATTERNS IN THE UNITED STATES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2866\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2866|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/46/4845\" title=\"table 1\">",
"      DRI selected nutrients children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/60/6093\" title=\"table 2\">",
"      Dietary guidelines children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/41/30365\" title=\"table 3\">",
"      Toddler to early school age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/62/19437\" title=\"table 4\">",
"      School age children to adol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/42/18091\" title=\"table 5\">",
"      Sources dietary fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/17/4381\" title=\"table 6\">",
"      Safe food handling practices",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/5/21594?source=related_link\">",
"      Childhood lead poisoning: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=related_link\">",
"      Dietary history and recommended dietary intake in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=related_link\">",
"      Fish oil and marine omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16426?source=related_link\">",
"      Food poisoning in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=related_link\">",
"      Introducing solid foods and vitamin and mineral supplementation during infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=related_link\">",
"      Management of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=related_link\">",
"      Nutritional issues in food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=related_link\">",
"      Poor weight gain in children older than two years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=related_link\">",
"      Preventive dental care and counseling for infants and young children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18442="Reflex syncope";
var content_f18_0_18442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Reflex syncope",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/0/18442/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/0/18442/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reflex (neurally mediated) syncope is a transient loss of consciousness due to a reflex response that encompasses vasodilatation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bradycardia (rarely tachycardia), leading to systemic hypotension and cerebral hypoperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ]. Types of reflex syncope include vasovagal syncope, situational syncope, carotid sinus syncope, and atypical forms (without apparent triggers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atypical presentation) (",
"    <a class=\"graphic graphic_table graphicRef64301 \" href=\"UTD.htm?8/31/8701\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Vasovagal syncope (also known as neurocardiogenic syncope) is the most common cause of syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/2\">",
"     2",
"    </a>",
"    ]. The diagnosis may be suggested or diagnosed by a specific history with well-known triggers, but a classic history is not required. The diagnosis can also be made by exclusion of other causes of syncope and by a characteristic response to upright tilt table testing during which the patient may pass out from bradycardia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypotension.",
"   </p>",
"   <p>",
"    The following discussion primarily applies to patients with recurrent syncope. Acute vasovagal reactions leading to syncope or presyncope are common also in a number of stressful settings, such as blood donation. They do not necessarily recur or require treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=see_link&amp;anchor=H23#H23\">",
"     \"Procedures used for blood donor screening: Protection of potential blood donors and recipients\", section on 'Vasovagal syncope'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vasovagal syncope and situational syncope will be reviewed here. General discussions of the pathogenesis, etiology, and evaluation of syncope, and issues related to carotid sinus hypersensitivity and glossopharyngeal neuralgia, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=see_link\">",
"     \"Pathogenesis and etiology of syncope\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/22/10598?source=see_link\">",
"     \"Carotid sinus hypersensitivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of craniofacial pain\", section on 'Glossopharyngeal neuralgia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vasovagal syncope is a cause of acute postural hypotension. Other causes of postural hypotension are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=see_link\">",
"     \"Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=see_link\">",
"     \"Postural tachycardia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF REFLEX SYNCOPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Understanding the physiology involved in reflex syncope is essential to understanding its clinical manifestations. Both neural (Bezold-Jarisch and carotid sinus reflexes) and endogenous chemical pathways are thought to be involved (",
"    <a class=\"graphic graphic_figure graphicRef80233 \" href=\"UTD.htm?37/2/37926\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1383552\">",
"    <span class=\"h2\">",
"     Cardioinhibitory and vasodepressor responses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in autonomic activation are responsible for reflex syncope. Three types of responses are seen: a cardioinhibitory response, a vasodepressor response, and a mixed response with features of both [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cardioinhibitory response results from increased parasympathetic activation and may be manifested by any or all of the following: sinus bradycardia, asystole, PR prolongation, and advanced atrioventricular block.",
"     </li>",
"     <li>",
"      The vasodepressor response is due to inhibition of (decreased) sympathetic activity and can lead to hypotension. In one report, for example, the final trigger for symptomatic hypotension appeared to be the abrupt disappearance of muscle sympathetic nerve activity [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/5\">",
"       5",
"      </a>",
"      ]. Reduced cardiopulmonary baroreceptor sensitivity may be a contributing factor [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An individual patient may have separate syncopal events characterized by a primary vasodepressor, cardioinhibitory or mixed responses, but the episodes can vary in their presentation for any individual such that asystole may occur at one time and hypotension at another. Furthermore, the response observed during tilt table testing is not necessarily the same as that recorded during clinical episodes. Asystolic pauses are more common during spontaneous episodes, but hypotension is more common during tilt table testing (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Electrocardiographic monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Vasovagal syncope may be caused by autonomic cardioinhibitory",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vasodilator responses. It is likely that sensory inputs through vagal afferents, pain pathways, and central pathways (visual, temporal lobe, and other inputs) affect the nucleus tractus solitarius to cause sympathoinhibition and vagal efferent activation.",
"   </p>",
"   <p>",
"    The most frequent mechanism for vasovagal syncope is a cardioinhibitory response, as illustrated in a selected population of 111 patients with presumed vasovagal syncope who received an implantable loop recorder and were followed for 3 to 15 months [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/7\">",
"     7",
"    </a>",
"    ]. Syncope recurred in 34 percent; a correlation between syncope and electrocardiographic (ECG) changes was found in 84 percent. The most frequent abnormality (seen in 50 percent) was one or more prolonged asystolic pauses, primarily due to sinus arrest; bradycardia (&lt;40 beats per min) without pauses was seen in 9 percent. The remaining patients had normal sinus rhythm or sinus tachycardia and probably had a vasodepressor response. Presyncope was usually associated with sinus rhythm and was never associated with asystole.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Autonomic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomic dysfunction contributes to reflex syncope, particularly in those with the atypical presentation, starting in old age and often associated with cardiovascular or neurologic disorders, which may include orthostatic or postprandial hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ]. Autonomic dysfunction is also thought to play a role in some vasovagal syncope, but vasovagal syncope also occurs without apparent autonomic dysfunction. Bezold-Jarisch and carotid sinus reflexes may be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients may have increased muscle sympathetic nerve activity at rest and a blunted response to orthostatic stress [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bezold-Jarisch reflex &mdash; Receptors in the atria, great veins, and left ventricle exist whose activation results in the Bezold-Jarisch reflex. Activation of the mechanoreceptors in the left ventricle and stretch receptors in the great vessels with pressure or volume loading (as may occur with sympathetic stimulation) stimulate C fibers; such stimulation may result in activation of vagal afferents and then vagal efferents.",
"     </li>",
"     <li>",
"      Carotid sinus reflex &mdash; Blood pressure and heart rate are normally controlled in part by input from baroreceptors located within the carotid sinus and aortic arch. An increase in blood pressure or pressure applied to the carotid sinus enhances the baroreceptor firing rate and activates vagal efferents, thereby slowing the heart rate and reducing the blood pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Central serotonergic pathways",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central serotonergic pathways appear to participate in the pathogenesis of vasovagal syncope, an observation that provides the rationale for the use of selective serotonin reuptake inhibitors in this disorder. (See",
"    <a class=\"local\" href=\"#H1384696\">",
"     'Other medications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Drugs that enhance central serotonergic activity, such as fenfluramine and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , increase the plasma levels of prolactin and cortisol and have been used to evaluate the activity of the serotonergic system. One study administered clomipramine to 20 subjects, eight of whom had a history of vasovagal syncope; those with a history of syncope had higher levels of prolactin and cortisol compared with controls without syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/9\">",
"     9",
"    </a>",
"    ]. Furthermore, serum concentrations of prolactin and cortisol obtained during tilt table testing (without clomipramine) were significantly elevated only in those subjects with a positive test.",
"   </p>",
"   <p>",
"    Further support for the role of central serotonergic pathways comes from a study in which",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    therapy increased the number of patients with a history of syncope who had a positive tilt table test (80 versus 53 percent without therapy); the drug had no effect in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Adenosine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The observation that adenosine administration can provoke reflex syncope raises the possibility that endogenous adenosine plays a role in the pathogenesis of vasovagal syncope. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Adenosine administration'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    This hypothesis was evaluated in a study of 26 patients with unexplained syncope who underwent upright tilt table testing; plasma adenosine was measured at baseline, immediately after tilting, and at 45 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/11\">",
"     11",
"    </a>",
"    ]. The 11 patients with syncope induced by tilt table test had much higher plasma adenosine values at all three time periods. Plasma adenosine increased by about 50 percent above baseline during tilt-induced syncope, and the higher the value, the shorter the time to appearance of symptoms.",
"   </p>",
"   <p>",
"    These observations suggest that adenosine release, perhaps mediated by mechanoreceptors in the heart, may be involved in the triggering mechanism of syncope, at least during tilt testing. Adenosine has a variety of actions, including negative chronotropic and inotropic activity and vasodepression [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other mechanisms may contribute to vasovagal syncope. These include adenosine receptor activation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/12\">",
"     12",
"    </a>",
"    ] and impaired cerebral autoregulation characterized by cerebral vasoconstriction just prior to the loss of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. The latter problem is also called cerebral syncope and can occur in the absence of systemic hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/14,16\">",
"     14,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1383393\">",
"    <span class=\"h1\">",
"     VASOVAGAL SYNCOPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasovagal (neurocardiogenic) syncope (also known as the &ldquo;common faint&rdquo;) refers to a variety of clinical scenarios in which a neural reflex results in usually self-limited systemic hypotension characterized by bradycardia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peripheral vasodilation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/17\">",
"     17",
"    </a>",
"    ]. It is the most common cause of syncope (approximately 20 to 35 percent of cases), particularly in patients without apparent cardiac or neurologic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/18-24\">",
"     18-24",
"    </a>",
"    ]. However, reflex syncope is the most common cause of syncope even among patients with heart disease and should be considered as a potential cause in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vasovagal syncope is a common cause of syncope in athletes. However, other potential causes of syncope should be considered and evaluated before identifying the etiology of syncope, particularly if the syncope occurs during exertion. Athletes with syncope during physical activity should be evaluated for potential risk of sudden death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23192?source=see_link&amp;anchor=H2#H2\">",
"     \"Arrhythmia in athletes\", section on 'Syncope'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history, physical examination, and specific testing all may be important (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with vasovagal syncope are most commonly young and otherwise healthy. Typical triggers and premonitory symptoms are strongly suggestive of vasovagal syncope, although these may be absent or difficult to correlate to the syncopal episode. Women and patients younger than 40 are more likely to have typical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/25\">",
"     25",
"    </a>",
"    ]. However, older patients are also frequently diagnosed with vasovagal syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/26\">",
"     26",
"    </a>",
"    ]. Older individuals have specific triggers that may be absent in younger individuals (ie, micturition, cough, defecation, deglutition).",
"   </p>",
"   <p>",
"    Vasovagal syncope (&ldquo;classical&rdquo;) refers to syncope triggered by emotional or orthostatic stress such as venipuncture (experienced or witnessed), painful or noxious stimuli, fear of bodily injury, prolonged standing, heat exposure, or exertion.",
"   </p>",
"   <p>",
"    This is in contrast to the &ldquo;atypical form&rdquo; of reflex syncope (also referred to as &ldquo;non-classical&rdquo; presentation). Some patients, especially those who are older, have recurrent episodes of syncope without an identifiable cause or trigger.",
"   </p>",
"   <p>",
"    Vasovagal syncope is often associated with a prodrome and persistence of nausea, pallor, and diaphoresis, consistent with increased vagal tone. Syncope is typically of short duration and occurs in the sitting or standing position. The supine position restores adequate blood flow to the brain. However, full recovery may be delayed as the patient may feel depressed or fatigued. This course may help distinguish vasovagal syncope from syncope associated with arrhythmia, which is typically of abrupt onset and of short duration. Loss of consciousness may be prolonged with some other causes of syncope, such as seizures and aortic stenosis, but rarely with vasovagal syncope. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    History can be very helpful in making the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1,27\">",
"     1,27",
"    </a>",
"    ]. As noted in the 2009 European Society of Cardiology (ESC) guidelines, syncope precipitated by emotional distress or orthostatic stress and associated with typical prodrome is diagnostic of vasovagal syncope. Further evaluation with tilt table test is not indicated if diagnostic vasovagal features are identified and further testing will not alter treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5662493\">",
"    <span class=\"h3\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of vasovagal syncope includes other causes of syncope (",
"    <a class=\"graphic graphic_table graphicRef64301 \" href=\"UTD.htm?8/31/8701\">",
"     table 1",
"    </a>",
"    ) as well as nonsyncopal conditions that produce apparent or real transient loss of consciousness (eg, falls, transient ischemic attacks, seizures) (",
"    <a class=\"graphic graphic_table graphicRef76023 \" href=\"UTD.htm?23/58/24491\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of syncope in adults\", section on 'General principles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vasovagal syncope is a cause of acute postural hypotension. Other causes of postural hypotension are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=see_link\">",
"     \"Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=see_link\">",
"     \"Postural tachycardia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Older patients, unlike younger patients, may have a combination of vasovagal syncope, carotid sinus hypersensitivity,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    orthostatic hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/28,29\">",
"     28,29",
"    </a>",
"    ] and are more likely to have co-existing cardiovascular disease and to be taking medications. In older patients, patients with syncope during exertion, and other patients who may have structural heart disease, potential causes of syncope other than a vasovagal response should be excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Upright tilt table test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tilt table test is a commonly performed test for the evaluation of syncope in which the diagnosis of vasovagal syncope is suspected but not clear based upon initial evaluation, and ruling out vasovagal syncope is important (",
"    <a class=\"graphic graphic_table graphicRef60161 \" href=\"UTD.htm?25/11/25789\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. However, the tilt table test has limited specificity, sensitivity, and reproducibility. A detailed discussion of the tilt table test is found elsewhere (",
"    <a class=\"graphic graphic_table graphicRef60161 \" href=\"UTD.htm?25/11/25789\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27399?source=see_link\">",
"     \"Upright tilt table testing in the evaluation of syncope\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted in the 2009 ESC guidelines, tilt table testing is recommended for patients with unexplained single syncopal episodes in high-risk settings, or recurrent episodes in the absence of organic heart disease, or in the presence of organic heart disease after cardiac causes have been excluded (",
"    <a class=\"graphic graphic_table graphicRef60161 \" href=\"UTD.htm?25/11/25789\">",
"     table 3",
"    </a>",
"    ). Tilt table testing is also recommended when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient. Tilt table testing is reasonable to discriminate between reflex and orthostatic hypotension syncope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Adenosine administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenosine or the related precursor compound adenosine triphosphate (ATP) provokes a short and potent cardioinhibitory response of vagal origin, including sinus bradycardia or pauses, atrioventricular (AV) block, and vasodepression. In various studies, a positive response to adenosine or adenosine triphosphate has been attributed to various diagnoses, including sick sinus syndrome, AV block, and vasovagal syncope. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H45#H45\">",
"     \"Evaluation of syncope in adults\", section on 'Adenosine and adenosine triphosphate (ATP)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adenosine has been considered to have a potentially complementary role to the tilt table test, but its role still remains undefined. There are several reasons to be cautious about the use and interpretation of the adenosine and ATP tests. These included limited data on the specificity of positive responses and paucity of data on the impact of therapy in patients with positive responses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H45#H45\">",
"     \"Evaluation of syncope in adults\", section on 'Adenosine and adenosine triphosphate (ATP)'",
"    </a>",
"    .) A limitation of ATP and tilt table tests is that both are poorly correlated with the mechanism of spontaneous syncope as detected by implantable loop recorder [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of ATP (or adenosine) to evaluate syncope is not FDA approved, and ATP infusion is not a standard test in the US at this time. The 2009 ESC guidelines note that there is a lack of correlation of spontaneous syncope to the results of the ATP test and have determined that it is not a diagnostic test for pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Electrocardiographic monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with frequent symptoms, relatively short-term (one month) noninvasive electrocardiographic monitoring (eg, an external loop recorder) may suffice. Since syncopal episodes often occur less frequently (eg, less than once per month), longer-term monitoring options have been developed.",
"   </p>",
"   <p>",
"    The implantable loop recorder (ILR) is a subcutaneous monitoring device for the detection of cardiac arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/33\">",
"     33",
"    </a>",
"    ]. Such a device is typically implanted in the left pectoral region and has a battery life of 18 to 24 months. It stores events when the device is activated automatically according to programmed criteria or manually with magnet application. The use of ILR and other electrocardiographic monitoring in the diagnosis of syncope generally is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H34#H34\">",
"     \"Evaluation of syncope in adults\", section on 'Implantable loop recorder'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted in the 2009 ESC guidelines, ILR is recommended in early-phase evaluation of patients with recurrent syncope of uncertain origin, absence of high-risk criteria (",
"    <a class=\"graphic graphic_table graphicRef78397 \" href=\"UTD.htm?20/26/20908\">",
"     table 4",
"    </a>",
"    ), and high likelihood of recurrence within battery longevity of the device [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef57636 \" href=\"UTD.htm?13/62/14317\">",
"     table 5",
"    </a>",
"    ). ILR is also recommended in high-risk patients in whom a comprehensive evaluation did not establish a cause of syncope or lead to a specific treatment. ILR may be reasonable to assess the contribution of bradycardia before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic episodes.",
"   </p>",
"   <p>",
"    ILRs may more accurately establish a causative relationship between bradyarrhythmias and syncope than provocative tests (eg, upright tilt table test or ATP infusion) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. This was illustrated in a series of 392 patients without significant electrocardiographic or cardiac abnormalities who underwent ILR implantation after three or more syncopal episodes in two years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/32\">",
"     32",
"    </a>",
"    ]. Patients with orthostatic hypotension and carotid sinus syncope were excluded.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      343 patients underwent tilt table testing, which was positive in 164 (48 percent), and 180 underwent ATP infusion, which was positive in 53 (29 percent).",
"     </li>",
"     <li>",
"      Syncope was documented by ILR in 106 patients (26 percent) after a median of three months.",
"     </li>",
"     <li>",
"      Patients with positive and negative tilt tests had similar baseline characteristics, syncopal recurrence rate, and mechanism of spontaneous syncope.",
"     </li>",
"     <li>",
"      Patients with positive and negative ATP test responses had similar syncopal recurrence rates and mechanisms of syncope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, among patients with recurrent vasovagal syncope, the rhythm documented by ILR during spontaneous recurrent syncope did not correlate with the results of provocative tests. These findings suggest that provocative tests (tilt table and ATP tests) have little value in guiding specific therapy.",
"   </p>",
"   <p>",
"    The potential utility of ILR in guiding use of pacing therapy for syncope is discussed below. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Cardiac pacemakers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A limitation to use of ILR is that it can be difficult to distinguish an asystolic or bradyarrhythmic event that is vasovagal from one that is related to sinus node disease, and even if asystolic episodes occur in association with vasovagal reflex, they may occur after syncope has already occurred due to hypotension.",
"   </p>",
"   <p>",
"    The safety and efficacy of early ILR use to guide therapy were evaluated in an observation study of 392 patients with recurrent suspected vasovagal syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/35\">",
"     35",
"    </a>",
"    ]. Among 106 patients with a recurrent syncopal episode recorded by ILR, 53 had therapy guided by this information (pacemakers in more than 80 percent), while the remaining patients had no specific therapy, primarily because an arrhythmic cause was not identified. Recurrence rates were low among those with ILR-guided therapy (10 versus 41 percent among those who did not have an indication for and therefore did not receive ILR-guided therapy).",
"   </p>",
"   <p>",
"    The risks associated with a prolonged ILR were relatively low. Seven patients (2 percent) suffered major trauma from syncope recurrence during ILR monitoring, and four patients (1 percent) developed ILR pocket infections. These risks should be balanced against the risks of early provocative testing; these include both false positive results, which may lead to unnecessary therapies, as well as false negative results, which may delay diagnosis. Limited data suggest that use of an ILR is cost effective compared with conventional approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H49#H49\">",
"     \"Evaluation of syncope in adults\", section on 'Cost for evaluation of syncope'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy is primarily aimed at patients with",
"    <strong>",
"     recurrent",
"    </strong>",
"    syncope. Acute vasovagal reactions are common in a number of stressful settings, such as blood donation. Patients who develop syncope or other symptoms associated with the vasovagal reflex should assume the supine position with legs raised at the onset of such symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=see_link&amp;anchor=H23#H23\">",
"     \"Procedures used for blood donor screening: Protection of potential blood donors and recipients\", section on 'Vasovagal syncope'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No therapy has been proven effective for recurrent vasovagal syncope. Some intuitively appealing therapies have not proven effective. Therapy is particularly important in patients who have recurrent syncope in high-risk settings (eg, commercial vehicle driver, pilot) and who wish to continue these activities. Patients with recurrent episodes may require restriction of activities until therapy is shown to be effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Explanation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with vasovagal syncope should be provided with reassurance and education regarding the nature, risks, and prognosis of the condition (",
"    <a class=\"graphic graphic_table graphicRef67864 \" href=\"UTD.htm?19/62/20460\">",
"     table 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/30\">",
"     30",
"    </a>",
"    ]. The patient should be advised to assume the supine position with legs raised at the onset of symptoms. The patient should be advised to avoid trigger events when feasible, and medications that may induce hypotension should be modified or discontinued.",
"   </p>",
"   <p>",
"    A study of self-reported symptom burden in 418 patients diagnosed with vasovagal syncope indicated that 35 percent were symptom free at median five-year follow-up, regardless of presenting symptom or treatment received [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2009 ESC guidelines noted that tilt training may be useful for education of patients but that long-term benefit depends on compliance [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1384119\">",
"    <span class=\"h3\">",
"     Physical counterpressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have found that isometric activity, such as crossing the legs and the arms, may be helpful to offset a syncopal response, but release of this position may be associated with precipitous decline in heart rate and blood pressure. Counter-pressure maneuvers, such as tensing the arms with clenched fists, leg pumping, and leg-crossing may abort a syncopal episode or at least delay it long enough that patients can assume the supine position [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/37\">",
"     37",
"    </a>",
"    ]. Physical counterpressure maneuvers are intended to reduce lower-extremity venous pooling and therefore improve cardiac output and prevent vasovagal syncope. Such maneuvers include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leg-crossing with simultaneous tensing of leg, abdominal, and buttock muscles.",
"     </li>",
"     <li>",
"      Handgrip, which consists of maximum grip on a rubber ball or similar object.",
"     </li>",
"     <li>",
"      Arm tensing, which involves gripping one hand with the other while simultaneously abducting both arms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential efficacy of these maneuvers was evaluated in a randomized trial of 223 patients with recurrent vasovagal syncope and recognizable prodromal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients were randomly assigned to lifestyle modification (eg, avoidance of triggers, increasing fluid and salt intake, lying down at the onset of prodromal symptoms), or lifestyle modification plus physical counterpressure maneuvers. Patients assigned to counterpressure were instructed on the three maneuvers described above, with biofeedback to monitor blood pressure response during instruction. They were then advised to use the maneuver of their choice at the onset of symptoms and maintain it as long as tolerated, or until symptoms resolved, and to move on to a second or third maneuver if necessary. Over a mean follow-up of 14 months, patients assigned to counterpressure maneuvers were significantly less likely to have recurrent syncope compared with those assigned to lifestyle modification alone (32 versus 51 percent).",
"   </p>",
"   <p>",
"    The 2009 ESC guidelines recommend physical isometric counterpressure maneuvers in patients with reflex syncope with a prodrome. Along with explanation and reassurance, this is the only treatment for reflex syncope that can be strongly recommended at this time (",
"    <a class=\"graphic graphic_table graphicRef67864 \" href=\"UTD.htm?19/62/20460\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cardiac pacemakers",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4510171\">",
"    <span class=\"h4\">",
"     Rationale and limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is usually a significant bradycardic response in vasovagal syncope, there has been uncertainty about the role of pacemakers because of the severe vasodepressor reactions often found in this disorder. This is true even for those patients who have asystole during a tilt table test [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dual-chamber permanent pacing, especially with rate-drop response, should eliminate most, if not all, symptoms in patients with a pure cardioinhibitory response. When there is a sudden drop in heart rate within a defined range and duration, rate-drop response pacemakers pace at a faster rate (eg, 100 beats per min) for a prespecified period of time. Another slightly simpler mode of pacing used in some patients with reflex syncope is rate hysteresis, which involves pacing at a back-up rate (eg, 80 bpm), which is higher than the escape rate (eg, 40 bpm). The rate drop response function may be more effective since it enables greater tailoring of pacing therapy than rate hysteresis, though limited comparative data are available [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/40\">",
"     40",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In the patient with a mixed response (significant cardioinhibitory and vasodepressor components), dual-chamber permanent pacing may blunt the vasodepressor-related symptoms. However, many patients with recurrent vasovagal syncope experience a significant fall in blood pressure prior to any significant decline in heart rate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/41\">",
"     41",
"    </a>",
"    ], so pacemakers that sense only changes in heart rate cannot provide pacing in a timely manner. Close-loop stimulation pacing has been studied as a potential means of overcoming this limitation. (See",
"    <a class=\"local\" href=\"#H4510247\">",
"     'Closed loop stimulation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4510209\">",
"    <span class=\"h4\">",
"     Evidence on efficacy of pacemakers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence from clinical trials suggests a limited role for pacemaker therapy in patients with vasovagal syncope. A meta-analysis of nine randomized trials (two double blind and seven open label or single blind; total n = 430) of permanent pacemaker therapy for vasovagal syncope showed no overall benefit from pacemaker implantation and suggested that in the unblinded trials, an \"expectation effect\" led to an overestimation of the benefits of pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/42\">",
"     42",
"    </a>",
"    ]. Both double blind trials included in the meta-analysis (VPS II and SYNPACE) showed no statistically significant improvement with pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, the subsequent double blind ISSUE-3 trial enrolling 77 patients suggested that an implantable loop recorder (ILR) may be helpful in identifying patients with recurrent vasovagal syncope who have asystole and are likely to respond to pacemaker therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/45\">",
"     45",
"    </a>",
"    ]. The ISSUE-3 trial found a borderline statistically significant reduction in two-year syncope recurrence (25 percent with pacemaker ON versus 57 percent with pacemaker OFF; p = 0.039) in patients with history of recurrent syncope who were identified by ILR as having either &ge;3 s asystole with syncope or &ge;6 s asystole without syncope. Five patients had procedural complications including four with lead dislodgment requiring correction and one with subclavian vein thrombosis. A possible reason for the difference in results between the ISSUE-3 trial and earlier double-blind trials is that the ISSUE-3 trial used ILR to identify candidates for pacing in contrast to use of tilt testing as a criterion in earlier trials. As noted above, ILR may more accurately identify a causative relationship between bradyarrhythmias and syncope than tilt table testing or adenosine administration. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Electrocardiographic monitoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In summary, pacemaker therapy is not likely to be helpful as a general treatment for patients with vasovagal syncope but a small trial suggests it may be helpful in selected patients with recurrent syncope who are demonstrated to have asystole &ge;3 s with syncope or asystole &ge;6 s without syncope.",
"   </p>",
"   <p>",
"    Evidence on the efficacy of closed loop pacing is discussed below. (See",
"    <a class=\"local\" href=\"#H4510247\">",
"     'Closed loop stimulation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4510425\">",
"    <span class=\"h4\">",
"     Indications for pacing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the above evidence and clinical experience, pacing therapy is NOT considered first-line therapy for most patients with vasovagal syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1,17\">",
"     1,17",
"    </a>",
"    ]. In considering pacemaker therapy, it is important to document whether the predominant cause of symptoms is cardioinhibitory or vasodepressor, if possible. Pacing is more likely to be beneficial if the episodes are cardioinhibitory and unlikely to be beneficial if the primary problem is vasodepressor. However, it may be difficult to make this distinction, since the tilt table response does not always correlate with the response during clinical episodes. In evaluating the efficacy of pacing therapy, it must be confirmed that symptomatic benefit is clearly attributed to pacing, that the benefit is maintained long term, and that there is a consensus regarding the definition of treatment success or failure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/46\">",
"     46",
"    </a>",
"    ]. The potential benefit of pacing should be weighed against the potential harm including the risk of procedural complications. Use of closed loop stimulation to treat refractory reflex syncope is discussed below. (See",
"    <a class=\"local\" href=\"#H4510247\">",
"     'Closed loop stimulation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Although the 2008",
"    <span class=\"nowrap\">",
"     ACC/AHA/HRS",
"    </span>",
"    guidelines refer to use of tilt-table testing to guide therapy of vasovagal therapy, implantable loop recorder capture of spontaneous episodes appears to be a more accurate means of identifying whether a cardioinhibitory mechanism is responsible. Therefore, an implantable loop recorder may help guide therapy (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Electrocardiographic monitoring'",
"    </a>",
"    above). The above described ISSUE-3 trial as well as prior observational studies suggest that long-term electrocardiographic monitoring (eg, via ILR) may be helpful in identifying a subset of patients with syncope with documented symptomatic spontaneous bradycardia who are more likely to respond to pacing therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/35,45,47\">",
"     35,45,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4510240\">",
"    <span class=\"h4\">",
"     Major society guidelines on pacing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following recommendations are included in the 2008 American College of Cardiology",
"    <span class=\"nowrap\">",
"     (ACC)/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (AHA)/Heart",
"    </span>",
"    Rhythm Society (HRS) device guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Permanent pacing may be considered for significantly symptomatic vasovagal syncope associated with bradycardia documented spontaneously or at the time of tilt-table testing.",
"     </li>",
"     <li>",
"      Permanent pacing is",
"      <strong>",
"       not",
"      </strong>",
"      indicated for situational vasovagal syncope in which avoidance behavior is effective and preferred.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We agree with the later recommendation and with the following recommendations from the 2009 ESC guidelines regarding pacing for reflex syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef67864 \" href=\"UTD.htm?19/62/20460\">",
"     table 6",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac pacing is reasonable in patients with frequent recurrent reflex syncope, age &gt;40 years, and documented spontaneous cardioinhibitory response during monitoring.",
"     </li>",
"     <li>",
"      Cardiac pacing is",
"      <strong>",
"       not",
"      </strong>",
"      indicated in the absence of a documented cardioinhibitory reflex.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4510247\">",
"    <span class=\"h4\">",
"     Closed loop stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed loop stimulation (CLS) pacing incorporates a sensing system that monitors beat to beat changes in right ventricular impedance, which rises when right ventricular blood volume falls. A CLS unit can be programmed to pace at an increased rate when impedance abruptly rises, as during the onset of a vasovagal episode. Thus, pacemaker therapy can be initiated when blood pressure falls prior to the onset of a fall in heart rate. The following preliminary studies suggest that closed loop pacing may be an effective therapy for refractory vasovagal syncope:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      INVASY was a randomized, single blind, controlled study of patients with severe recurrent vasovagal syncope [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/48\">",
"       48",
"      </a>",
"      ]. All patients had a cardioinhibitory response to head-up tilt testing and received a CLS pacemaker. Patients were randomly assigned to received either DDD-CLS (17 patients) or DDI pacing (nine patients) during the first year of the study and 24 patients received DDD-CLS during the second year of the study. Seven of nine patients randomized to DDI mode had recurrences of syncope during the first year. The nine patients were then reprogrammed to the CLS mode and had no syncope after reprogramming. None of the 41 patients programmed to CLS mode had syncope during 19 months mean follow-up and only four reported occasional presyncope.",
"     </li>",
"     <li>",
"      A long-term observational study included 41 patients with recurrent refractory vasovagal therapy and a cardioinhibitory response to head up tilt testing [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/49\">",
"       49",
"      </a>",
"      ]. Twenty-five patients received a dual-chamber CLS pacemaker and 16 patients received a dual-chamber pacemaker with a conventional syncope prevention algorithm. During mean 4.4 year follow-up, there was a significantly lower rate of recurrent syncope in the CLS group compared to the conventional pacing group (4 versus 38 percent). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1384658\">",
"    <span class=\"h3\">",
"     Volume support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some have recommended support stockings (in some cases, Jobst stockings), volume expansion by liberalizing salt intake, and occasionally administration of the mineralocorticoid",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    (similar to the regimen used in the treatment of orthostatic hypotension). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"     \"Treatment of orthostatic and postprandial hypotension\"",
"    </a>",
"    .) Data are lacking to support this approach in treating reflex syncope, and these measures were not included in treatment recommendations for reflex syncope in the 2009 ESC guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1384665\">",
"    <span class=\"h3\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although beta blockers have been the most commonly used drug therapy for vasovagal syncope, available evidence does",
"    <strong>",
"     not",
"    </strong>",
"    support their efficacy. They may even be harmful in younger patients.",
"   </p>",
"   <p>",
"    They have been postulated to act upon the ill-defined afferent limb of the reflex arc involved in the Bezold-Jarisch reflex and to potentially also inhibit the discharge frequency of the C fibers originating from the cardiac mechanoreceptors and chemoreceptors (",
"    <a class=\"graphic graphic_figure graphicRef80233 \" href=\"UTD.htm?37/2/37926\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Initial observational data suggested a lower rate of recurrent syncope with beta blocker therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. However, at least four randomized trials have failed to show a benefit, due in part to a large placebo effect [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. Benefit of any therapy is difficult to demonstrate when the placebo effect is so high.",
"   </p>",
"   <p>",
"    The best data come from the POST trial, which enrolled 208 patients with recurrent syncope and an abnormal tilt table test [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/55\">",
"     55",
"    </a>",
"    ]. The patients were randomly assigned to treatment with placebo or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    , titrated to 200 mg daily or the highest tolerated dose (average dose 122 mg daily). At one year, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent syncope occurred in 36 percent of both groups.",
"     </li>",
"     <li>",
"      Withdrawal rates were 22 percent in both groups.",
"     </li>",
"     <li>",
"      Prespecified analyses according to age (categorized as &lt;42 versus &ge;42 years) and tilt table test results did not identify any subgroups that benefited with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/31/39417?source=see_link\">",
"       metoprolol",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2009 ESC guidelines note that beta blocking drugs are",
"    <strong>",
"     not",
"    </strong>",
"    recommended to treat reflex syncope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1384696\">",
"    <span class=\"h3\">",
"     Other medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of medications other than beta blockers have been used in the management of patients with vasovagal syncope. This includes: serotonin reuptake inhibitors, anticholinergics (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/49/35607?source=see_link\">",
"     disopyramide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/31/33264?source=see_link\">",
"     scopolamine",
"    </a>",
"    ), muscarinic blockers,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    , ACE inhibitors,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    , erythropoietin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , and others supported by limited data with few controlled trials.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"       Midodrine",
"      </a>",
"      , an alpha-1-adrenergic agonist, had a beneficial effect in a small randomized trial and a number of observational studies [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/57-60\">",
"       57-60",
"      </a>",
"      ]. The benefits have ranged from prevention of syncopal episodes in 95 percent of previously untreated patients [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/58\">",
"       58",
"      </a>",
"      ] to efficacy for up to 22 months in as many as 78 percent of patients who failed to respond to a beta blocker or other conventional therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/59,60\">",
"       59,60",
"      </a>",
"      ]. However, the efficacy of midodrine is uncertain, and another alpha agonist, etilefrine, was ineffective in a placebo-controlled study of 126 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/61\">",
"       61",
"      </a>",
"      ]. The ESC 2009 guidelines consider midodrine of uncertain benefit for reflex syncope (in contrast to its utility for orthostatic hypotension) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"       \"Treatment of orthostatic and postprandial hypotension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There has been interest in the use of selective serotonin uptake inhibitors, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/56,62,63\">",
"       56,62,63",
"      </a>",
"      ]. Their effect is at the level of the central nervous system, but it is unclear if it is at the afferent or efferent limb of the reflex arc. The potential clinical efficacy was illustrated in a randomized trial of paroxetine versus placebo in 68 consecutive patients with recurrent syncope and a positive upright tilt test in whom beta blockers, vagolytic agents, and mineralocorticoids were ineffective or poorly tolerated [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/62\">",
"       62",
"      </a>",
"      ]. Paroxetine significantly increased the likelihood of a negative tilt test at one month (62 versus 38 percent) and reduced the rate of spontaneous syncope during follow-up (18 versus 53 percent).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/49/35607?source=see_link\">",
"       Disopyramide",
"      </a>",
"      may be useful due to its negative inotropic (inhibition of myocardial mechanoreceptors) and anticholinergic properties [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/64\">",
"       64",
"      </a>",
"      ]. However, despite apparent benefit in observational studies [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/64,65\">",
"       64,65",
"      </a>",
"      ], a small controlled trial showed that the rate of recurrent syncope at 29 months was similar with disopyramide and placebo (27 versus 30 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A preliminary report of seven patients refractory to all other medical therapies suggested benefit from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"       methylphenidate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/67\">",
"       67",
"      </a>",
"      ]. This agent shares some properties with the amphetamines: it is a peripheral vasoconstrictor and stimulates the central nervous system.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"       Theophylline",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/68\">",
"       68",
"      </a>",
"      ] and angiotensin-converting enzyme inhibitors [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/69\">",
"       69",
"      </a>",
"      ] have been tried in small studies with some apparent success. Theophylline may be most effective in patients with a mixed response and associated fatigue during the episodes, although there are no data to support this clinical observation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Orthostatic training program",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with vasovagal syncope respond poorly to general measures. Orthostatic or tilt training may be an effective approach, although study results have been mixed [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/70-75\">",
"     70-75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of orthostatic training started in hospital and continued at home was suggested by a controlled but non-randomized study. Forty-seven patients with recurrent syncope and a positive upright tilt table test who were refractory to traditional therapies were assigned to a tilt-training program or to continued medical therapy, depending upon their consent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/70\">",
"     70",
"    </a>",
"    ]. The training program included five daily in-hospital upright tilt table studies increasing in duration from 10 to 50 minutes. The training program was continued at home with the patient instructed to stand against a wall for up to 40 minutes twice a day, under supervision of a family member.",
"   </p>",
"   <p>",
"    At a mean follow-up of 18 months, nearly all patients in the training group became tilt-negative (96 versus 26 percent of the control group). None of the trained patients had spontaneous recurrent syncope, compared with 57 percent of controls during 15 to 23 months of follow-up.",
"   </p>",
"   <p>",
"    However, four randomized controlled studies found that home orthostatic training in patients with syncope and positive tilt table tests did not reduce tilt-positive responses or spontaneous syncopal events [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/72-75\">",
"     72-75",
"    </a>",
"    ]. In one of these studies, there was a decrease in recurrent syncope with training in the subset of patients with vasodepressor type syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Moderate exercise training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited uncontrolled data suggest that moderate exercise training may increase orthostatic tolerance in patients with syncope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Driving restrictions for patients with vasovagal syncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although vasovagal syncope generally has a benign prognosis, a frequent concern is the potential for injury, particularly during certain activities, such as driving. One study evaluated the risk of driving-related injuries in 155 patients with a history of syncope in whom hypotension and syncope or presyncope was provoked during a tilt table study; 34 percent had no warning before syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/76\">",
"     76",
"    </a>",
"    ]. After the diagnosis of vasovagal syncope was established, six patients stopped driving voluntarily. All patients were treated pharmacologically. During a median follow-up of 22 months, 3.2 percent of patients had recurrent syncope, but no patient experienced syncope or injury while driving.",
"   </p>",
"   <p>",
"    Further insight was provided in a second study of 245 patients undergoing a tilt table study [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/77\">",
"     77",
"    </a>",
"    ]. Nine percent had experienced at least one episode of syncope while driving. After treatment, syncope or presyncope recurred in six (67 percent) of these patients, and there was one syncope-related driving incident.",
"   </p>",
"   <p>",
"    In cases where patients are counseled to abstain from driving because of concerns about recurrent syncope, adherence appears to be very low [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recommendations for driving in patients with neurally mediated syncope are included in the 1996 statement from the American Heart Association (AHA) and North American Society of Pacing and Electrophysiology (NASPE, now Heart Rhythm Society, HRS) on personal and public safety issues related to arrhythmias and were unchanged in the 2007 addendum [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/79,80\">",
"     79,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Driving recommendations in both the 1996",
"    <span class=\"nowrap\">",
"     AHA/NASPE",
"    </span>",
"    statement and the 2009 ESC syncope update are stratified according to whether syncope is categorized as \"mild\" or \"severe\":",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild neurally mediated syncope is characterized by infrequent mild symptoms (usually without syncope), occurring with warning and usually only with standing, with clear precipitating causes, and infrequent occurrence.",
"     </li>",
"     <li>",
"      Severe neurally mediated syncope is characterized by severe symptoms (usually syncope), occurring without warning and in any position, with no clear precipitating causes,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      frequent occurrence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the ESC guidelines, syncope during \"high-risk\" activity (eg, driving, machine operator, flying, competitive athletics) is also considered severe.",
"   </p>",
"   <p>",
"    The 1996",
"    <span class=\"nowrap\">",
"     AHA/NASPE",
"    </span>",
"    statement recommends no driving restrictions for private drivers with mild syncope. For commercial drivers with mild syncope, driving is permitted after arrhythmia control is documented for one month. For private or commercial drivers with untreated severe syncope, driving is prohibited. For private drivers treated for severe syncope, driving is permitted after arrhythmia control is documented for three months with adequate pacemaker follow-up as indicated. For commercial drivers treated for severe syncope, driving is permitted after arrhythmia control is documented for six months with adequate pacemaker follow-up as indicated.",
"   </p>",
"   <p>",
"    The 2009 ESC guidelines recommend no restriction with a single mild episode of vasovagal syncope in a private driver (",
"    <a class=\"graphic graphic_table graphicRef79808 \" href=\"UTD.htm?26/59/27580\">",
"     table 7",
"    </a>",
"    ). If there are recurrent and severe episodes, private drivers are allowed to return to driving after symptoms are controlled. For a professional driver, no restriction is recommended for a single mild episode, unless it occurs during high-risk activity. For recurrent and severe episodes, permanent restriction is recommended unless effective treatment has been established.",
"   </p>",
"   <p>",
"    Legal requirements for clinicians to report patients with conditions that could impair safe motor vehicle operation vary by state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SITUATIONAL SYNCOPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Situational syncope refers to syncope associated with specific scenarios.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Types and pathogenesis of situational syncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some situations (eg, postmicturition, cough, or post-tussive) appear to trigger a neural reflex; others (eg, straining, squatting) may cause syncope via mechanisms unrelated to neural reflexes. However, treatment strategies for these conditions are similar.",
"   </p>",
"   <p>",
"    Postmicturition syncope is a form of situational vasovagal syncope that accounts for up to 5 percent of cases of syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/18,19,81\">",
"     18,19,81",
"    </a>",
"    ]. The cause for this type of syncope is probably related to an abrupt change in position combined with a strong vagal stimulus (",
"    <a class=\"graphic graphic_figure graphicRef69675 \" href=\"UTD.htm?26/9/26781\">",
"     figure 2",
"    </a>",
"    ). Initial studies suggested a clear male predominance in this condition; however, one report found a higher incidence of syncope after evening micturition in women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several forms of situational syncope are associated with gastrointestinal stimuli (swallowing, defecation, visceral pain).",
"   </p>",
"   <p>",
"    Rarely, cough syncope has been reported as a symptom associated with an intracranial space-occupying lesion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical presentation and diagnosis of brain tumors\", section on 'Generalized'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identification of situational syncope is generally by clinical history. Patients with situational syncope often have positive responses to carotid sinus massage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tilt table testing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/83\">",
"     83",
"    </a>",
"    ], but the utility of such responses in guiding therapy has not been determined.",
"   </p>",
"   <p>",
"    The differential diagnosis is similar to that for vasovagal syncope. (See",
"    <a class=\"local\" href=\"#H5662493\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of most forms of situational syncope is based upon avoiding or ameliorating the triggering activity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"     1",
"    </a>",
"    ]. When the activity cannot be avoided, general treatment measures include maintenance of intravascular volume, protected posture (eg, sitting rather than standing) and slow postural changes. Specific measures may be helpful for certain conditions, such as use of stool softeners in those with defecation syncope, avoidance of excessive fluid intake (especially alcohol) prior to bedtime in postmicturition syncope, and avoidance of large gulps of cold drinks or boluses of food in swallow syncope.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Driving restrictions for patients with situational syncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for driving in patients with vasovagal syncope but not situational syncope are included in the 1996",
"    <span class=\"nowrap\">",
"     AHA/NASPE",
"    </span>",
"    statement or in the 2007 addendum [",
"    <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/79,80\">",
"     79,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Driving recommendations in the 2009 ESC syncope guideline update (as well as the 1996",
"    <span class=\"nowrap\">",
"     AHA/NASPE",
"    </span>",
"    statement) are stratified according to whether syncope is categorized as \"mild\" or \"severe\" (",
"    <a class=\"graphic graphic_table graphicRef79808 \" href=\"UTD.htm?26/59/27580\">",
"     table 7",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Driving restrictions for patients with vasovagal syncope'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If situational syncope is",
"      <span class=\"nowrap\">",
"       single/mild,",
"      </span>",
"      no restriction is recommended for private drivers and no restriction is recommended for vocational drivers \"unless syncope occurred during high risk activity.\" (However, the syncope would be classified as severe in that case).",
"     </li>",
"     <li>",
"      If situational syncope is severe, driving restriction is recommended for private drivers until appropriate therapy is established and for commercial drivers until effective treatment has been established.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/5/36946?source=see_link\">",
"       \"Patient information: Syncope (fainting) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/9/4245?source=see_link\">",
"       \"Patient information: Syncope (fainting) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of vasovagal syncope and situational syncope is suggested by history in patients who have classic triggers and premonitory symptoms. In other patients, the cause of syncope may be more difficult to identify.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasovagal (neurocardiogenic) syncope is caused by cardioinhibitory (bradycardia or asystole)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vasodepressor mechanisms.",
"     </li>",
"     <li>",
"      Clinical features typical of vasovagal syncope may be diagnostic. In such cases, further testing is indicated only when it will affect therapy.",
"     </li>",
"     <li>",
"      Tilt table testing is recommended for patients with unexplained single syncopal episodes in high-risk settings or recurrent episodes in the absence of organic heart disease or in the presence of organic heart disease after cardiac causes have been excluded (",
"      <a class=\"graphic graphic_table graphicRef60161 \" href=\"UTD.htm?25/11/25789\">",
"       table 3",
"      </a>",
"      ). Tilt table testing is also recommended when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.",
"     </li>",
"     <li>",
"      Cardiac rhythms during spontaneous syncopal episodes can be captured by implantable loop recorder so that the presence or absence of a cardioinhibitory mechanism during spontaneous syncope can be accurately identified. However, acquisition of diagnostic recordings may take months if episodes are infrequent. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Electrocardiographic monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy for vasovagal and situational syncope is generally reserved for patients who have had recurrent episodes of syncope (",
"      <a class=\"graphic graphic_table graphicRef67864 \" href=\"UTD.htm?19/62/20460\">",
"       table 6",
"      </a>",
"      ) .",
"     </li>",
"     <li>",
"      The initial approach is focused upon education in lifestyle modification and avoidance of medication or other triggers (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Explanation'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      For patients with recurrent episodes of vasovagal syncope, we recommend physical counterpressure techniques. (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      )&nbsp;(See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients &gt;40 years of age with recurrent syncope with vasovagal bradycardic or asystolic syncopal episodes documented by electrocardiographic monitoring with frequency of attacks &gt;5 per year or severe physical injury or accident, we suggest permanent cardiac pacing. (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In such patients, a closed loop stimulation (CLS) pacemaker may be considered. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Cardiac pacemakers'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      Among patients who continue to have recurrent syncope, the efficacy of further therapy is limited. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients diagnosed with recurrent vasovagal syncope, we recommend",
"      <strong>",
"       not",
"      </strong>",
"      treating with beta blockers. (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H1384665\">",
"       'Beta blockers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recommendations for driving restrictions generally depend on the severity of the syncopal episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?18/0/18442/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Driving restrictions for patients with situational syncope'",
"      </a>",
"      above.)&nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/1\">",
"      Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30:2631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/2\">",
"      Chen-Scarabelli C, Scarabelli TM. Neurocardiogenic syncope. BMJ 2004; 329:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/3\">",
"      Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation 2000; 102:2898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/4\">",
"      Chen MY, Goldenberg IF, Milstein S, et al. Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol 1989; 63:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/5\">",
"      Morillo CA, Eckberg DL, Ellenbogen KA, et al. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 1997; 96:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/6\">",
"      Thomson HL, Wright K, Frenneaux M. Baroreflex sensitivity in patients with vasovagal syncope. Circulation 1997; 95:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/7\">",
"      Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001; 104:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/8\">",
"      B&eacute;chir M, Binggeli C, Corti R, et al. Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation 2003; 107:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/9\">",
"      Theodorakis GN, Markianos M, Livanis EG, et al. Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Circulation 1998; 98:2724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/10\">",
"      Theodorakis GN, Markianos M, Zarvalis E, et al. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol 2000; 36:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/11\">",
"      Saadjian AY, L&eacute;vy S, Franceschi F, et al. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 2002; 106:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/12\">",
"      Waxman MB, Asta JA. Role of adenosine receptors in the paradoxic bradycardia response of rats to inferior vena cava occlusion during an infusion of isoproterenol. Circulation 1998; 98:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/13\">",
"      Diehl RR, Linden D, Chalkiadaki A, et al. Transcranial Doppler during neurocardiogenic syncope. Clin Auton Res 1996; 6:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/14\">",
"      Grubb BP, Samoil D, Kosinski D, et al. Cerebral syncope: loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pacing Clin Electrophysiol 1998; 21:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/15\">",
"      Carey BJ, Manktelow BN, Panerai RB, Potter JF. Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope. Circulation 2001; 104:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/16\">",
"      Chuang YM, Hu HH, Pan PJ. Cerebral syncope: insights from Valsalva maneuver. Eur Neurol 2005; 54:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/17\">",
"      Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/18\">",
"      WAYNE HH. Syncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients. Am J Med 1961; 30:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/19\">",
"      Mathias CJ, Deguchi K, Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet 2001; 357:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/20\">",
"      Engelstein, ED, Hutchins, GD, Sawada, S, et al. Normal cardiac sympathetic innervation in patients with neurocardiac syncope (abstract). J Am Coll Cardiol 1998; 31:165A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/21\">",
"      Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 2001; 37:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/22\">",
"      Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med 2002; 347:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/23\">",
"      Colivicchi F, Ammirati F, Biffi A, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J 2002; 23:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/24\">",
"      Sakaguchi S, Shultz JJ, Remole SC, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol 1995; 75:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/25\">",
"      Romme JJ, van Dijk N, Boer KR, et al. Influence of age and gender on the occurrence and presentation of reflex syncope. Clin Auton Res 2008; 18:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/26\">",
"      Tan MP, Parry SW. Vasovagal syncope in the older patient. J Am Coll Cardiol 2008; 51:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/27\">",
"      van Dijk N, Boer KR, Colman N, et al. High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study. J Cardiovasc Electrophysiol 2008; 19:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/28\">",
"      McIntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a 'syncope' clinic. Age Ageing 1993; 22:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/29\">",
"      Alboni P, Brignole M, Menozzi C, et al. Clinical spectrum of neurally mediated reflex syncopes. Europace 2004; 6:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/30\">",
"      Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001; 22:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/31\">",
"      Oribe E, Caro S, Perera R, et al. Syncope: the diagnostic value of head-up tilt testing. Pacing Clin Electrophysiol 1997; 20:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/32\">",
"      Brignole M, Sutton R, Menozzi C, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 2006; 27:2232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/33\">",
"      Krahn AD, Klein GJ, Skanes AC, Yee R. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing Clin Electrophysiol 2004; 27:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/34\">",
"      Deharo JC, Jego C, Lanteaume A, Djiane P. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test. J Am Coll Cardiol 2006; 47:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/35\">",
"      Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006; 27:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/36\">",
"      Ross R, Parry S, Norton M, Newton JL. Self-reported symptom burden; outcome in 418 patients from the Newcastle Vasovagal (Neurocardiogenic) cohort. QJM 2008; 101:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/37\">",
"      Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002; 40:2053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/38\">",
"      van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 2006; 48:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/39\">",
"      Lacroix D, Kouakam C, Klug D, et al. Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic implications. Pacing Clin Electrophysiol 1997; 20:2746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/40\">",
"      Ammirati F, Colivicchi F, Toscano S, et al. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope. Pacing Clin Electrophysiol 1998; 21:2178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/41\">",
"      Kosinski DJ, Grubb BP, Wolfe DA. Permanent cardiac pacing as primary therapy for neurocardiogenic (reflex) syncope. Clin Auton Res 2004; 14 Suppl 1:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/42\">",
"      Sud S, Massel D, Klein GJ, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med 2007; 120:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/43\">",
"      Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003; 289:2224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/44\">",
"      Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004; 25:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/45\">",
"      Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012; 125:2566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/46\">",
"      Benditt DG. Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/47\">",
"      Sud S, Klein GJ, Skanes AC, et al. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace 2007; 9:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/48\">",
"      Occhetta E, Bortnik M, Audoglio R, et al. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace 2004; 6:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/49\">",
"      Palmisano P, Zaccaria M, Luzzi G, et al. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. Europace 2012; 14:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/50\">",
"      Cox MM, Perlman BA, Mayor MR, et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995; 26:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/51\">",
"      Natale A, Sra J, Dhala A, et al. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol 1995; 18:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/52\">",
"      Ventura R, Maas R, Zeidler D, et al. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002; 25:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/53\">",
"      Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001; 37:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/54\">",
"      Flevari P, Livanis EG, Theodorakis GN, et al. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002; 40:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/55\">",
"      Sheldon R, Connolly S, Rose S, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006; 113:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/56\">",
"      Theodorakis GN, Leftheriotis D, Livanis EG, et al. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 2006; 8:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/57\">",
"      Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998; 79:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/58\">",
"      Mitro P, Trejbal D, Ryb&aacute;r AR. Midodrine hydrochloride in the treatment of vasovagal syncope. Pacing Clin Electrophysiol 1999; 22:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/59\">",
"      Klingenheben T, Credner S, Hohnloser SH. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers. Pacing Clin Electrophysiol 1999; 22:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/60\">",
"      Samniah N, Sakaguchi S, Lurie KG, et al. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001; 88:A7, 80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/61\">",
"      Raviele A, Brignole M, Sutton R, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999; 99:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/62\">",
"      Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 33:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/63\">",
"      Grubb BP, Samoil D, Kosinski D, et al. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994; 24:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/64\">",
"      Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990; 65:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/65\">",
"      Kelly PA, Mann DE, Adler SW, et al. Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing. Pacing Clin Electrophysiol 1994; 17:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/66\">",
"      Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/67\">",
"      Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol 1996; 19:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/68\">",
"      Nelson SD, Stanley M, Love CJ, et al. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 1991; 151:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/69\">",
"      Zeng C, Zhu Z, Liu G, et al. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J 1998; 136:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/70\">",
"      Di Girolamo E, Di Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study. Circulation 1999; 100:1798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/71\">",
"      Reybrouck T, Heidb&uuml;chel H, Van de Werf F, Ector H. Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000; 23:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/72\">",
"      Foglia-Manzillo G, Giada F, Gaggioli G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 2004; 6:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/73\">",
"      On YK, Park J, Huh J, Kim JS. Is home orthostatic self-training effective in preventing neurally mediated syncope? Pacing Clin Electrophysiol 2007; 30:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/74\">",
"      Gurevitz O, Barsheshet A, Bar-Lev D, et al. Tilt training: does it have a role in preventing vasovagal syncope? Pacing Clin Electrophysiol 2007; 30:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/75\">",
"      Duygu H, Zoghi M, Turk U, et al. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study. Pacing Clin Electrophysiol 2008; 31:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/76\">",
"      Bhatia A, Dhala A, Blanck Z, et al. Driving safety among patients with neurocardiogenic (vasovagal) syncope. Pacing Clin Electrophysiol 1999; 22:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/77\">",
"      Li H, Weitzel M, Easley A, et al. Potential risk of vasovagal syncope for motor vehicle driving. Am J Cardiol 2000; 85:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/78\">",
"      Maas R, Ventura R, Kretzschmar C, et al. Syncope, driving recommendations, and clinical reality: survey of patients. BMJ 2003; 326:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/79\">",
"      Epstein AE, Miles WM, Benditt DG, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996; 94:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/80\">",
"      Epstein AE, Baessler CA, Curtis AB, et al. Addendum to \"Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology\": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society. Circulation 2007; 115:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/81\">",
"      Linzer M, Yang EH, Estes NA 3rd, et al. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997; 126:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/82\">",
"      Kapoor WN, Peterson JR, Karpf M. Micturition syncope. A reappraisal. JAMA 1985; 253:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/0/18442/abstract/83\">",
"      Brignole M, Menozzi C, Gianfranchi L, et al. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991; 122:1644.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1050 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-E8883B2495-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18442=[""].join("\n");
var outline_f18_0_18442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS OF REFLEX SYNCOPE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1383552\">",
"      Cardioinhibitory and vasodepressor responses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Autonomic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Central serotonergic pathways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Adenosine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1383393\">",
"      VASOVAGAL SYNCOPE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5662493\">",
"      - Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Upright tilt table test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Adenosine administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Electrocardiographic monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Explanation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1384119\">",
"      - Physical counterpressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cardiac pacemakers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4510171\">",
"      Rationale and limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4510209\">",
"      Evidence on efficacy of pacemakers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4510425\">",
"      Indications for pacing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4510240\">",
"      Major society guidelines on pacing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4510247\">",
"      Closed loop stimulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1384658\">",
"      - Volume support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1384665\">",
"      - Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1384696\">",
"      - Other medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Orthostatic training program",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Moderate exercise training",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Driving restrictions for patients with vasovagal syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SITUATIONAL SYNCOPE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Types and pathogenesis of situational syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Driving restrictions for patients with situational syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1050\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1050|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/2/37926\" title=\"figure 1\">",
"      Neural pathways in syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/9/26781\" title=\"figure 2\">",
"      Pacemaker vs drug treatment for syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1050|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/31/8701\" title=\"table 1\">",
"      Classification of syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/58/24491\" title=\"table 2\">",
"      Conditions incorrectly diagnosed as syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/11/25789\" title=\"table 3\">",
"      Recommendations for tilt testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/26/20908\" title=\"table 4\">",
"      Risk stratification for syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/62/14317\" title=\"table 5\">",
"      Electrocardiographic monitoring for syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/62/20460\" title=\"table 6\">",
"      Treatment of reflex syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/59/27580\" title=\"table 7\">",
"      Recommendations for driving in patients with syncope",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23192?source=related_link\">",
"      Arrhythmia in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/22/10598?source=related_link\">",
"      Carotid sinus hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=related_link\">",
"      Clinical presentation and diagnosis of brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/41/12951?source=related_link\">",
"      Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=related_link\">",
"      Pathogenesis and etiology of syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/9/4245?source=related_link\">",
"      Patient information: Syncope (fainting) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/5/36946?source=related_link\">",
"      Patient information: Syncope (fainting) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=related_link\">",
"      Postural tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=related_link\">",
"      Procedures used for blood donor screening: Protection of potential blood donors and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27399?source=related_link\">",
"      Upright tilt table testing in the evaluation of syncope",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_0_18443="Causes of secondary dysmenorrhea";
var content_f18_0_18443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of secondary dysmenorrhea",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Gynecologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Endometriosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenomyosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovarian cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrauterine or pelvic adhesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic pelvic inflammatory disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obstructive&nbsp;endometrial polyps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital obstructive m&uuml;llerian malformations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use of an intrauterine contraceptive device",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic congestion syndrome&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Nongynecologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Irritable bowel syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uteropelvic junction obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychogenic disorders",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18443=[""].join("\n");
var outline_f18_0_18443=null;
var title_f18_0_18444="Parenteral regimens in pyelonephritis";
var content_f18_0_18444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral regimens for empiric treatment of complicated pyelonephritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antimicrobial agent&nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose, interval",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Mild to moderate pyelonephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ceftriaxone",
"       </td>",
"       <td>",
"        1 g every 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cefepime",
"       </td>",
"       <td>",
"        1 g every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ciprofloxacin",
"       </td>",
"       <td>",
"        400 mg every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Levofloxacin",
"       </td>",
"       <td>",
"        750 mg every 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aztreonam*",
"       </td>",
"       <td>",
"        1 g every 8 to 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Severe pyelonephritis with immunocompromise and/or incomplete urinary drainage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ampicillin-sulbactam",
"       </td>",
"       <td>",
"        1.5 g every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ticarcillin-clavulanate",
"       </td>",
"       <td>",
"        3.1 g every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Piperacillin-tazobactam",
"       </td>",
"       <td>",
"        3.375 g every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Meropenem",
"       </td>",
"       <td>",
"        500 mg every 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Imipenem",
"       </td>",
"       <td>",
"        500 mg every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doripenem&nbsp;",
"       </td>",
"       <td>",
"        500 mg every 8 hours&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Previous antimicrobial use and results of any recent urine cultures should inform the choice of an empiric regimen.",
"    <br>",
"     Doses are for patients with normal renal function.",
"     <br>",
"      In the setting of pregnancy the above agents are acceptable with the exceptions of ciprofloxacin, levofloxacin, and imipenem. The treatment of urinary tract infection due to enterococcus is discussed separately.",
"      <br>",
"       If methicillin-resistant S. aureus (MRSA) is known or suspected, see treatment regimens outlined separately in topics addressing MRSA management.",
"       <div class=\"footnotes\">",
"        * Alternative in the setting of beta lactam allergy.",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18444=[""].join("\n");
var outline_f18_0_18444=null;
var title_f18_0_18445="Low sodium diet B";
var content_f18_0_18445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Low-sodium diet (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Foods to choose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Foods to avoid",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Breads:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Whole-grain breads, English muffins, bagels",
"      </td>",
"      <td>",
"       Biscuits, prepared mixes (pancake, muffin, cornbread)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Cereals:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cooked hot cereals (not instant), such as oatmeal, cream of wheat, rice, or farina; puffed wheat; puffed rice; shredded wheat",
"      </td>",
"      <td>",
"       Instant hot cereals, many boxed cold cereals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Crackers and snack foods:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       All unsalted crackers and snack foods, unsalted peanut butter, unsalted nuts or seeds",
"      </td>",
"      <td>",
"       Salted crackers and snack items (chips, pretzels, popcorn), regular peanut butter, prepared dips/spreads, salted nuts or seeds",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Pasta, rice, and potatoes:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Any type of pasta; potatoes; white or brown rice",
"      </td>",
"      <td>",
"       Macaroni and cheese mix; rice, noodle, or spaghetti mixes; canned spaghetti; frozen lasagna; instant potatoes; seasoned potato mixes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Dried beans and peas:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Any dried beans or peas without seasoning",
"      </td>",
"      <td>",
"       Beans or peas prepared with ham, bacon, salt pork, or bacon grease; all canned beans",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Meats and alternatives:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fresh or frozen beef, poultry, and fish; low-sodium canned tuna and salmon; eggs",
"      </td>",
"      <td>",
"       Salted, smoked, canned, spiced, and cured meat, poultry, or fish; bacon; ham; sausage; lunch meats; hot dogs; breaded frozen meat, fish, or poultry; frozen dinners; pizza",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Fruits and vegetables:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Any fresh, frozen, or canned fruit, any fresh or frozen vegetables without sauce, canned vegetables without salt, low-salt tomato sauce/paste",
"      </td>",
"      <td>",
"       Regular canned vegetables and vegetable juices, regular tomato sauce and tomato paste, olives, pickles, relishes, sauerkraut, frozen vegetables in butter or sauces, crystallized and glazed fruit, maraschino cherries, fruit dried with sodium sulfite",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Dairy products:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Milk, cream, sour cream, non-dairy creamer, yogurt, low-sodium cottage cheese, low-sodium cheese",
"      </td>",
"      <td>",
"       Buttermilk, Dutch processed chocolate milk, processed cheese slices and spreads, processed cheese, cottage cheese, aged or natural cheese",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Fats and oils:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Plant oils (olive, canola, corn, peanut), unsalted butter or margarine",
"      </td>",
"      <td>",
"       Prepared salad dressings, bacon, salt pork, fat back, salted butter or margarine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Soups:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Salt-free soups and low-sodium bouillon cubes, unsalted broth, homemade soup without added salt",
"      </td>",
"      <td>",
"       Regular canned or prepared soups, stews, broths, or bouillon; packaged and frozen soups",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Desserts:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Gelatin, sherbet, pudding, ice cream, salt-free baked goods, sugar, honey, jam, jelly, marmalade, syrup",
"      </td>",
"      <td>",
"       Packaged baked goods",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Beverages:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Coffee, tea, soft drinks, fruit-flavored drinks, low-salt tomato juice, any fruit juice",
"      </td>",
"      <td>",
"       Softened water; carbonated beverages with sodium or salt added; regular tomato juice (V-8); ask about alcoholic beverages",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Condiments:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fresh and dried herbs; lemon juice; low-salt mustard, vinegar, Tabasco sauce; low- or no-salt ketchup; seasoning blends that do not contain salt",
"      </td>",
"      <td>",
"       Table salt, lite salt, bouillon cubes, meat extract, taco seasoning, Worcestershire sauce, tartar sauce, ketchup, chili sauce, cooking sherry and wine, onion salt, mustard, garlic salt, soy sauce, tamari, meat flavoring or tenderizer, steak and barbecue sauce, seasoned salt, monosodium glutamate (MSG), Dutch processed cocoa",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18445=[""].join("\n");
var outline_f18_0_18445=null;
var title_f18_0_18446="Effect of workplace smoking policy";
var content_f18_0_18446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Effect of workplace smoking policies on nicotine concentrations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 446px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The distribution of nicotine concentrations in workplaces as a function of smoking policy, and by office or other workplaces illustrates that a policy of banning smoking reduces nicotine concentrations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Hammond, SK, Environ Health Perspect 1999; 107:329.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18446=[""].join("\n");
var outline_f18_0_18446=null;
var title_f18_0_18447="CF colonization by age";
var content_f18_0_18447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 646px\">",
"   <div class=\"ttl\">",
"    Prevalence of bacteria identified in respiratory secretions from patients with cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 626px; height: 288px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MRSA: methicillin-resistant",
"     <em>",
"      Staphylococcus aureus",
"     </em>",
"     .",
"     <br>",
"      * Includes methicillin-resistant and methicillin-sensitive",
"      <em>",
"       S. aureus",
"      </em>",
"      .",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cystic Fibrosis Foundation Patient Registry, 2010 Annual Data Report, Bethesda, MD. Copyright &copy; 2011 Cystic Fibrosis Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_0_18447=[""].join("\n");
var outline_f18_0_18447=null;
